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Abstract
Background: Acquired brain injury (ABI) refers to multiple disabilities arising from damage to the brain acquired
after birth. Children with an ABI may experience physical, cognitive, social and emotional-behavioural impairments
which can impact their ability to participate in activities of daily living (ADL). Recent developments in technology
have led to the emergence of internet-delivered therapy programs. “Move it to improve it” (Mitii™) is a web-based
multi-modal therapy that comprises upper limb (UL) and cognitive training within the context of meaningful
physical activity. The proposed study aims to compare the efficacy of Mitii™ to usual care to improve ADL motor
and processing skills, gross motor capacity, UL and executive functioning in a randomised waitlist controlled trial.
Methods/Design: Sixty independently ambulant children (30 in each group) at least 12 months post ABI will be
recruited to participate in this trial. Children will be matched in pairs at baseline and randomly allocated to receive
either 20 weeks of Mitii™ training (30 min per day, six days a week, with a potential total dose of 60 h) immediately,
or be waitlisted for 20 weeks. Outcomes will be assessed at baseline, immediately post-intervention and at 20
weeks post-intervention. The primary outcomes will be the Assessment of Motor and Process Skills and 30 s
repetition maximum of functional strength exercises (sit-to-stand, step-ups and half kneel to stand). Measures of
body structure and functions, activity, participation and quality of life will assess the efficacy of Mitii™ across all
domains of the International Classification of Functioning, Disability and Health framework. A subset of children will
undertake three tesla (3T) magnetic resonance imaging scans to evaluate functional neurovascular changes,
structural imaging, diffusion imaging and resting state functional connectivity before and after intervention.
Discussion: Mitii™ provides an alternative approach to deliver intensive therapy for children with an ABI in the
convenience of the home environment. If Mitii™ is found to be effective, it may offer an accessible and inexpensive
intervention option to increase therapy dose.
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Background
Introduction
Acquired brain injury (ABI) is an umbrella term that re-
fers to any insult to the brain in the post-neonatal period
[1]. Generally, the minimum age for an ABI is 28 days
post full-term birth, allowing for a recognised event with
brain damaging potential (that is not likely to be attrib-
uted to any events in the intrauterine environment) in a
previously well infant [2]. Common causes of childhood
ABI include traumatic brain injury (TBI), stroke, infec-
tion, cerebral tumour, cerebral hypoxia or anoxia and
encephalitis [1]. Recent advances in medical response have
led to decreased mortality rates following brain injury (in-
cluding TBI, brain tumour and stroke), with more individ-
uals living with the sequelae of ABI [3]. Over 600,000
Australians have a brain injury with Queensland having the
highest prevalence (2.5 % compared to 1.8 % for the rest of
Australia) [1]. As many as two out of three of these people
acquired their brain injury before 25 years of age with the
majority sustaining a TBI [4]. The estimated lifetime cost
per incident case is AUD$ 4.8 million for moderate and se-
vere TBI of which 19 % is borne directly by state govern-
ments [3]. These figures include financial costs involved
with health care, equipment and modifications, long-term
care, productivity losses and burden of disease costs. This
highlights the importance of developing effective treat-
ments and interventions beyond acute medical care to en-
hance post-injury outcomes and minimise the economic
impact of ABI at an individual and government level.
Many children with an ABI experience persistent aca-
demic, occupational, physical, emotional-behavioural
and cognitive impairments leading to reduced quality
of life (QOL) [5–7]. Behavioural deficits, such as anx-
iety and depression may also deteriorate over time be-
cause of damage to specific areas of the brain and
increased aggression and hyperactivity may not mani-
fest until several years after injury [8, 9]. All of these
impairments impact on a child’s ability to successfully
participate in therapeutic interventions post discharge.
Secondary psychosocial factors including family mater-
ial and social resources, social disadvantage, stressors,
parent distress and general family functioning may also
emerge requiring long-term management by a multi-
disciplinary team [10].
Although motor outcomes recover more quickly than
cognitive skills after ABI, ongoing physical impairments
may remain. Physical impairment is closely related to
brain injury severity, whereby greater brain injury sever-
ity predicts poorer physical (and cognitive) outcomes
[5–7]. Common physical impairments following ABI in-
clude changes in muscle tone, impaired balance and sen-
sation, reduced strength and coordination [11, 12]. The
Australian Bureau of Statistics 2003 Survey of Disability,
Ageing and Carers found that nearly all of the 20,000
children (90 %) who were identified as having an ABI as
a main or associated diagnosis were reported to have
“severe or profound core activity limitations” [4]. Motor
difficulties impact a child’s ability to engage in activities
of daily living (ADL) such as getting dressed and walk-
ing. Recovery of functional abilities and support for on-
going acquisition of developmental skills is a key goal of
inpatient and outpatient rehabilitation so children can
return to participating in age appropriate activities.
Cognitive impairment is a common consequence of
ABI [5, 13–15], with children experiencing difficulties
with memory, attention, concentration, executive dys-
function and a potential decline in intellectual ability
over time [13, 14]. Previous studies have reported that it
is often executive control over cognitive processes, ra-
ther than specific processes themselves (e.g. memory)
that is impaired and requires rehabilitation [14–16].
Often such cognitive deficits following an ABI can lead to
poor school attainment, behavioural issues and impact
personal relations and employment opportunities [14].
Upper Limb (UL) interventions
Even though ABI is one of the leading causes of long-
term disability in children and young adults, there is
limited evidence to guide choice of therapy. There is
preliminary low level evidence for bimanual training
(BIM), forced used therapy and modified-Constraint In-
duced Movement Therapy (mCIMT) to improve UL
function in children with an ABI [17–21]. Forced use
therapy was compared to a control group in a rando-
mised controlled trial (RCT) for 25 children with ABI
aged one to eight years [19]. Forced use involved con-
tinuous casting of the unimpaired UL for one month
with continuation of regular occupational therapy and
physiotherapy. Forced use therapy led to improved fine
motor skills, as measured on the Peabody Developmen-
tal Motor Scales, compared to the control group [19].
A recent RCT compared two intensive UL approaches
in 33 children with unilateral cerebral palsy (CP) and 14
children with non-progressive hemiplegia (stroke and
TBI) [20]. Children either received 60 h of mCIMT and
20 h of BIM or 80 h of BIM training over four weeks.
Both interventions led to a significant improvement in
hand motor function, however mCIMT yielded greater
changes in unimanual capacity (as measured by the Mel-
bourne Assessment of Unilateral Upper Limb Function,
MUUL) [20]. Data for the subgroup of children with an
ABI were not reported separately due to the small num-
bers, therefore it is unclear the extent of treatment effect
in children with an ABI [20]. Three studies have investi-
gated the use of mCIMT for children with an ABI using
case series design [18, 17, 21]. A pilot study investigated
the effectiveness of 40 h of mCIMT over four weeks in
eight children aged 6 to 15 years at least one year after
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arterial ischaemic stroke. After mCIMT there were no
improvements in sensorimotor function or quality of UL
movement (MUUL) [21]. All children reportedly im-
proved occupational performance goals as measured on the
Canadian Occupational Performance Measure (COPM)
and Goal Attainment Scaling (GAS) however, no data were
provided [21]. A second study of 10 children aged 8 to 12
years with TBI received mCIMT for three hours per day,
seven days a week over a 10 week period (total dose of 210
h) and demonstrated gains in dissociated movements and
grasp on the Quality of Upper Extremity Skills Test [18]. A
final study investigated mCIMT provided for six hours per
day, five days per week over two weeks (total dose of 60 h)
for seven children with an ABI aged 7 to 17 years, demon-
strating gains in the amount and quality of use of the im-
paired UL [17]. It is difficult to compare results across trials
as they targeted different age groups, types of ABI and used
vastly different treatment protocols (total doses ranged
from 40 to 210 h). It appears, however, that at least 60 h of
intensive training was required to drive changes in UL
motor outcomes. This has implications for current thera-
peutic interventions in children with an ABI.
Limited evidence is available for other therapeutic in-
terventions such as repetitive Transcranial Magnetic
Stimulation (rTMS), motor imagery and mirror therapy
to improve UL function in children with an ABI [22].
Repetitive Transcranial Magnetic Simulation involves
non-invasive brain stimulation, delivered by a pulsed
magnetic field has been investigated in a small RCT of
10 children after stroke [23]. Improved grip strength was
evident after eight days of daily rTMS [23]. The majority
of evidence for motor imagery and mirror therapy has
been in adult ABI populations and although evidence is
promising, the methodological quality is limited [22].
Physical activity and functional strength interventions
Gross motor capacity refers to what movements (which
usually incorporate large muscle groups) a person can
do in a standardised environment [24]. There is prelim-
inary evidence to support the use of home-based exer-
cise programs to improve gross motor capacity in
children and adolescents with an ABI [25, 26]. One RCT
has evaluated the immediate and short term effects of a
home-based exercise program to improve functional cap-
acity for children aged 7 to 13 years with TBI (n = 10) and
CP (n = 10) [25]. The intervention consisted of six weeks
of task-oriented exercises including sit-to-stands and front
and sideways step-ups. Children in the intervention group
improved on motor and balance performance as measured
by the Timed Up and Go (TUG) test and Functional
Reach Test after six weeks of training [25]. The results for
the TBI group should however, be interpreted cautiously as
it is unknown whether results reached clinical significance
and whether a larger sample size would have demonstrated
greater changes.
Another non-randomised, within subject controlled
study investigated the effects of a supervised home-
based motor training program utilising sit-to-stands and
step-up exercises [26]. Nineteen children aged 5 to 15
years at least one year post ABI with a Glasgow Coma
Scale (GCS) equal to or less than eight at the time of
injury were included [26]. Children were evaluated at
baseline, after the control period (four weeks of no inter-
vention) and then four weeks post-intervention [26].
Within-group comparisons showed significant improve-
ments in walking speed, walking distance and balance
items on the Bruininks-Oseretsky Test of Motor Profi-
ciency (BOT-MP) [26]. These studies provide prelimin-
ary evidence for the use of home-based exercise
program to improve gross motor capacity in children
with an ABI.
Habitual Physical Activity (HPA) can be defined as any
bodily movement produced by skeletal muscles resulting
in energy expenditure [27]. Fitness level is an important
health indicator [28] and participation in regular phys-
ical activity is associated with improved self-efficacy to
perform ADL in children with a physical disability [29].
Understanding HPA patterns will provide insight into
both health status and functional ability for these chil-
dren. Habitual physical activity in children and adoles-
cents can be measured subjectively using self-report
questionnaires, activity logs and diaries as well as object-
ively using direct observation, doubly labelled water,
heart rate monitoring, accelerometers and pedometers
[30]. Accelerometers have become the most widely used
objective measure of physical activity as indirect calor-
imetry and direction observation are not feasible when
measuring HPA in free-living individuals [31]. The
amount of HPA in which children and adolescents with
an ABI participate has only been measured subjectively
using parental or self-report questionnaires and may be
prone to bias (e.g. incidental or unstructured activity
may be missed).
The World Health Organisation (WHO) recommends
that children and adolescents aged 5–17 years should ac-
cumulate at least 60 min of moderate to vigorous physical
activity [28] and the new Australian Physical Activity and
Sedentary Behaviour Guidelines also suggest limiting
screen time to less than two hours per day [32, 33]. Des-
pite the health benefits and recommended guidelines,
Australian children at least one year post-ABI are 25-75 %
less likely to participate at school, home and in the commu-
nity compared to their peers (as reported by caregivers)
and are at a higher risk of obesity and co-morbidities such
as hypertension [34, 35]. Despite these concerning reports,
no studies have evaluated the effect of any intervention on
HPA objective outcomes in children with an ABI.
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Cognitive interventions
Evidence for cognitive rehabilitation following paediatric
ABI has produced mixed results [36, 37]. Research for
children with an ABI has found that memory and atten-
tion respond better to targeted interventions than cogni-
tive functions (e.g. information processing speed) [14,
36, 38]. Cognitive rehabilitation techniques have been
demonstrated to be effective in adult populations however,
there is a paucity of research in the paediatric population
[14, 37]. Adult cognitive rehabilitation provides rationales
for effective strategies but does not consider the complex-
ities of a developing brain [14]. Evidence for attention re-
habilitation in a paediatric population has shown promise
for attention training and the use of compensatory strat-
egies to remediate attention difficulties following an ABI
[14]. There is limited evidence to support to use of specific
training strategies for aspects of memory and more sub-
stantial evidence for the use of compensatory and external
strategies to improve day to day memory functioning [14].
Executive functioning is often thought to underlie and
control cognitive processes, thus requiring rehabilitation
rather than the specific cognitive domains (e.g. attention
and memory) [15]. Studies so far have found efficacy for
cognitive and behavioural interventions, however these in-
terventions often require intensive support and specific
generalisation training [14]. Most research in executive
functioning interventions focuses on a single area of ex-
ecutive functioning e.g. problem solving [13, 14]. There is
a need for research grounded within a paediatric develop-
mental model of executive functioning in order to inform
evidence based interventions.
Virtual Reality (VR) technologies
Internet-delivered virtual reality (VR) technologies have
emerged as a feasible way to deliver intensive therapy to
children and adolescents with an ABI [39]. They have
the capacity to provide tailored therapy to children who
may be limited by resources in their demographically-
isolated communities. Virtual reality systems utilise
hardware and software options to create interactive sim-
ulations that embed and engage the user in realistic en-
vironments. Virtual reality systems relevant to paediatric
rehabilitation range from rehabilitation-specific tech-
nologies (e.g. GestureTek Interactive Rehabilitation Exer-
cise System) through to off-the-shelf gaming systems
(e.g. Nintendo Wii Sports and Wii Fit). In general, com-
mercially available systems offer a wider variety of games
however; their ability to manipulate and track therapeut-
ically relevant system variables (i.e. the ability to adjust
the number of repetitions, bodily movements that are
recognised, speed of stimulus, complexity and grading of
the challenge in games) are limited [40]. In contrast, re-
habilitation specific technologies offer a wider variety of
system variables that can be manipulated but have a
limited number of game options available [40].
Preliminary evidence for the use of VR technologies to
improve UL and lower limb (LL) activity outcomes for
children with an ABI is emerging. In a pilot study, Wille
et al. [41] used the rehabilitation specific Paediatric In-
tensive Therapy System, three sessions a week for three
weeks, to improve hand function in five children with
congenital and acquired brain injuries. A systematic re-
view of VR UL rehabilitation among an adult ABI popu-
lation reported moderate evidence for the use of VR to
improve general UL function (including motor function,
range of motion [ROM] and speed and dexterity) [42].
The majority of these studies have used small-sample or
case study designs and did not adequately report specific
brain injury characteristics.
A limited number of case studies to date have ex-
plored the effects of VR interventions to improve bal-
ance abilities in children and adolescents with an ABI.
Two case studies with small samples (n = 3; n = 2) inves-
tigated the use of the Nintendo Wii to improve dynamic
balance over a period of 3–4 weeks (total dose 2.5-6 h)
[43, 44] and another single case study used both the X-
box Kinect and Nintendo Wii to improve balance abil-
ities in a 10 year old male with a non-TBI over 4 weeks
(total combined dose of 7.5 h) [45]. All studies demon-
strated improved balance abilities post-intervention
however, two studies included participants less than a
year post-injury and it was unknown whether improve-
ments were due to the intervention or natural course of
recovery from the ABI [44, 45]. Although, there are no
known VR interventions targeted to improve functional
capacity in children with an ABI a systematic review
highlighted substantial evidence for the use of VR inter-
ventions over standard therapy in adults post-stroke
[46]. Interventions using either rehabilitation specific or
commercially available VR systems were significantly more
effective when compared to standard therapy to improve
functional capacity outcomes in this patient group. Fur-
ther investigations into the use of VR systems for UL and
LL rehabilitation in children with an ABI are warranted
and studies should also consider possible improvements
in cognitive function and societal participation.
“Move it to improve it” (Mitii™)
“Move it to improve it” (Mitii™) is an internet-based
multi-modal therapy program which comprises UL,
physical and cognitive training. The program was devel-
oped through collaboration between The Helene El-
sass Center, a private software development company
(Headfitted; Aarhus, Denmark) and the University of
Copenhagen [47]. The program design was under-
pinned by knowledge that training must be intense, in-
crementally challenging, motivating and long-lasting
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in order to drive neuroplastic changes in the brain
[48]. The original version of Mitii™ used green tracking
bands that were worn around the hands, knees or head
and tracked by a web-camera attached to the computer
[47]. The second generation Mitii™ is accessed in the indi-
vidual’s home via the internet and requires an internet-
connected computer and Microsoft Kinect® (2nd generation,
Redmond, Washington, USA) to track body movements.
Occupational therapists, physiotherapists and neuro-
psychologists act as remote “virtual trainers” and set up
individual programs for each child. The therapists re-
ceive feedback about the participant’s training perform-
ance (e.g. speed of performance and percentage of
answers correct) and adjustments to the program can be
made to provide incremental challenge. The feasibility of
the Mitii™ program has been confirmed in two studies of
children and adolescents with CP [49]. In a large RCT of
children with unilateral CP (n = 102) participants dem-
onstrated significant gains in ADL motor and processing
skills, UL speed and dexterity, visual perception and self-
perceived occupational performance after 20 weeks of
Mitii™ training [49]. Also a pre-post study of 34 children
with unilateral CP demonstrated significant gains in
functional strength compared to aged matched controls
after 20 weeks of training [50]. Both of these studies
achieved significant improvement in primary outcomes
across multiple domains even though the prescribed
intervention dose was not achieved.
Virtual reality interventions, such as Mitii™ provide the
opportunity for multi-modal training in home environ-
ments. A smaller, initial pilot study of investigating the
efficacy Mitii™ in the home environment has demon-
strated high adherence with over 85 % of participants
achieving or exceeding the recommended total dose over
20 weeks of training (average dose of 74 h) [47]. In con-
trast, the dose achieved in the two larger studies in
children with unilateral CP [49, 50] highlight the im-
portance of considering participant engagement and
motivational strategies during long home rehabilita-
tion/treatment protocols. Strategies to ensure partici-
pant engagement during therapy are an important
aspect to consider as they impact not only task per-
formance but rehabilitation outcomes.
Extrinsic rewards may promote initial engagement in
therapy whilst, intrinsic motivation is important for
long-term maintenance and ultimately, change in atti-
tudes and behaviour [51]. Extrinsic motivators are out-
side of the activity itself and may include rewards charts,
non-tangible and tangible incentives [52, 53]. These re-
wards provide satisfaction and pleasure that the indi-
vidual may not initially draw from the task. In contrast,
intrinsic motivation involves the sense of satisfaction
and pleasure from performing and completing activities
[52]. These activities will be different for each individual
and can include spending time with a friend whose com-
pany is enjoyed. Closely associated with intrinsic motiv-
ation is the act of setting goals and planning how to
achieve these within a set timeframe [54]. In paediatrics
this is often accomplished with parental involvement.
Additionally, providing parents with strategies to maintain
adherence also plays a significant role in a child’s motiv-
ation to perform and achieve goals [55].
Children with an ABI may have persistent physical, cog-
nitive and psychosocial problems requiring outpatient
therapy after discharge from hospital. The Mitii™ program
potentially offers an intensive, home-based multi-modal
training program which could increase the therapy dose
achieved. The training program can be individualised and
incremented according an individual’s level of ability –
which is a distinct advantage over commercially available
systems. Our proposed RCT of VR for children with an
ABI proposes an adequately powered sample, using valid
and reliable outcome measures (across all three domains
of the ICF) with the assessment of retention effects post-
intervention.
Aims and hypotheses
The primary aim of this proposed study is to compare 20
weeks of Mitii™ training to usual care to improve ADL
motor and processing skills, gross motor capacity, UL
activity (unimanual and bimanual) and cognitive skills in a
randomised, waitlist controlled trial for children and ado-
lescents with an ABI. Secondarily, we aim to investigate
the central neurovascular mechanisms underlying changes
in UL function, motor planning and executive functions.
This will be achieved by using functional magnetic reson-
ance imaging (fMRI), structural imaging (sMRI), diffusion
imaging (dMRI) and functional connectivity (FC) to meas-
ure central activation in the parts of the brain controlling
movement. Understanding the foundation of neuroplasti-
city changes is essential to developing effective treatments
with lasting effects. This proposed study aims to test the
efficacy of Mitii™ across all three domains of the ICF
(Table 1).
Primary hypotheses
Compared to usual care, Mitii™ training will achieve
significantly greater gains in:
1. Activities of daily living motor processing skills as
indicated by an improvement of a minimum
detectable change (MDC) of 0.5 logit scores on the
Assessment of Motor and Process Skills (AMPS)
immediately following training;
2. Gross motor capacity assessed by 30 s repetition
maximum (repmax) of functional strength exercises
(MDC = ≥28 repetitions on composite score of three
functional strength exercises)
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Secondary hypotheses
Compared to usual care, Mitii™ training will achieve
significantly greater:
1. Upper limb activity (unimanual and bimanual), as
measured on the Jebsen-Taylor Test of Hand
Function (JTTHF), MUUL and the Assisting Hand
Assessment (AHA) [56];
2. Lower limb gross motor capacity assessed using the
Timed Up and Go (TUG) test, 6-min Walk Test
(6MWT) and the High-Level Mobility Assessment
Tool (HiMAT);
3. Habitual physical activity (as measured on the
ActiGraph® accelerometer) [57];
4. Neurovascular (functional MRI) changes;
5. Visual perception (visual discrimination, visual
memory and visual sequential memory) measured
on the Test of Visual Perception Skills (TVPS) [58];
6. Executive functioning including information
processing, attentional control, cognitive flexibility,
goal setting, working memory and behavioural
manifestations in everyday life as measured by
subtests from the Delis-Kaplan Executive Function
System (D-KEFS), the Wechsler Intelligence Scale
for Children Fourth Edition (WISC-IV), the
Comprehensive Trail Making Test (CTMT), Tower
of London – Second Edition and the Behaviour
Rating Inventory of Executive Function (BRIEF);
7. Attention including performance on tasks of
attention (TEA-Ch) and attention in everyday life as
measured by parent rating (Conner’s 3);
8. Psychological functioning as measured by the
Strengths and Difficulties Questionnaire (SDQ);
9. Performance and satisfaction with occupational
performance goals using the COPM;
10. Participation as measured by the Child and
Adolescent Scale of Environment (CASE) and
Child and Adolescent Scale of Participation (CASP);
11. QOL on the domains of functioning and
participation as measured on the Kidscreen-52;
12. Parent reported functional abilities in self-care and
daily activities (using the MobQues28) [59]
Finally, Mitii™ will be more cost-effective compared with
usual care as shown by resource use and consequence
based on function (AMPS) and QOL (Child Health Utility
9D (CHU-9D) [60] and Kidscreen-52 [61])
Methods/design
Ethics
Full ethical approval for this study has been obtained by
the Medical Ethics Committee of The University of
Queensland (2013000212) and The Royal Children’s Hos-
pital, Brisbane (HREC/12/QRCH/222). Written and in-
formed consent will be obtained from all participants and
their parents or guardians before entering the trial. This
trial has been registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12613000403730).
Recruitment
Sixty children at least 12 months post an ABI, which
was acquired ≥28 days post full term birth will be re-
cruited into the Mitii™ study. To be eligible, participants
must be:
(i) Aged 8–16 years;
(ii) Independently ambulant at Gross Motor
Classification System (GMFCS) equivalent level I or
II [62];
(iii) Equivalent to a Manual Abilities Classification scale
(MACs) of I to III [63];
(iv) Co-operative and have sufficient cognitive
understanding, visual and verbal abilities to perform
the assessment and training tasks;
(v) Classified with a brain injury which was acquired
greater than 28 days after birth (based on the
Table 1 Measures according to ICF domains
Impairment Activity Participation
and
Environment
Classifier and Predictor Variables: Primary Outcomes: Classifier
Variable:
GMFCS, MACS, Edinburgh
Handedness Inventory, Height,
Range of Motion, Stereognosis,
M2PD, Texture Tactile Perception,
Mirror Movements, WISC-IV, Study
questionnaire
AMPS PEM-CY
30 s repmax of
functional strength
exercises
Secondary Outcomes: Secondary
Outcomes:
Secondary
Outcomes:
JTTHF AHA COPM
MUUL 6MWT CASE
Executive Function: Score!, Sky
Search and Sky Search DT from
the TEA-Ch, Digit Span, Coding,
and Symbol Search from WISC-IV;
CTMT; TOL; Colour-Word Interfer-
ence Test from D-KEFS; BRIEF;
TVPS
HiMAT CASP
TUG test Kidscreen-52
4 day ActiGraph
accelerometer
CHU-9D
SDQ
Legend: AHA, Assisting Hand Assessment; AMPS, Assessment of Motor and
Process Skills; BRIEF, Behaviour Rating Inventory of Executive Function; CASE,
Child and Adolescent Scale of Environment; CASP, Child and Adolescent Scale
of Participation; CHU-9D, Child Health Utility 9D; COPM, Canadian Occupational
Performance Measure; CTMT, Comprehensive Trail-Making Test; D-KEFS, The
Delis-Kaplan Executive Function System; GMFCS, Gross Motor Function
Classification System; HiMAT, High-Level Mobility Assessment Tool; JTTHF, Jebsen
Taylor Test of Hand Function; MACS, Manual Ability Classification System; MUUL,
Melbourne Assessment of Unilateral Upper Limb Function; M2PD, Moving 2-Point
Discrimination; PEM-CY, Participation and Environment Measure for Children and
Youth; repmax, repetition maximum; SDQ, Strength and Difficulties Questionnaire;
TEA-Ch, Test of Everyday Attention for Children; TOL, Tower of London test; TUG
test, Timed Up and Go test; TVPS, Test of Visual Perception Skills; WISC-IV,
Wechsler Intelligence Scale for Children – fourth edition; 6MWT, 6-min Walk Test
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Australasian Rehabilitation Outcomes Centre
impairment codes) [64]. For TBI, classified as mild
complicated, moderate or severe brain injury;
(vi) Able to participate in the study over a period of 12
months;
(vii) Able to access the internet at home.
Children will be excluded if they have:
(i) A degenerative or metabolic condition;
(ii) Unstable epilepsy (i.e. frequent seizures not
controlled by medication);
(iii) Undergone any surgical or any medical intervention
impacting on UL and LL function in the past six
months as this will confound results.
All children will undergo a comprehensive screen by a
rehabilitation consultant to confirm eligibility. Partici-
pants will be recruited through referral by treating clinical
staff (paediatricians, neuropsychologists physiotherapists,
occupational therapists and speech therapists) from the
Queensland Paediatric Rehabilitation Service (QPRS),
Brisbane, Australia who will ask families if they are willing
to be contacted regarding potential involvement in the
study. Following verbal consent, study personnel will pro-
vide participant information and seek informed consent.
To assist recruitment, participants will be reimbursed for
travel expenses and flexible times and locations for assess-
ments will be arranged.
Design
This study utilises a matched-pairs, randomised waitlist
controlled trial (see Fig. 1 for CONSORT flow chart). A
matched pairs design was chosen to minimise the risk of
baseline between-group differences. A waitlist design en-
sures that all participants have access to this novel inter-
vention and will facilitate recruitment into the study.
Within each pair, each participant will be randomised
into either:
a) Immediate intervention group: Families return home
with Mitii™ equipment and commence training
immediately for 20 weeks and then Mitii™ is
withdrawn; or
b) Waitlist delayed intervention (control) group:
Families continue care as usual for 20 weeks, return
to Brisbane for a one day re-assessment and then
return home with Mitii™ equipment to commence
training for 20 weeks. Care as usual includes any
therapies (for example, occupational therapy and
physiotherapy) usually provided by public or private
services and visits to their treating paediatrician or
general practitioner. Information about each
participant’s usual care during the study period will
be gathered using a general study questionnaire.
After re-assessment the participants (and their
family) will receive the Mitii™ introduction and
equipment ready to commence training.
To limit confounding variables during the immediate
intervention period (baseline to 20 week follow up), it
will be requested that participants delay any of the fol-
lowing concomitant treatments – casting, splinting,
intramuscular botulinum toxin type A [BoNT-A] injec-
tions (to UL or LL) and surgery. Participants will be able
to continue other usual care therapies. Participants who
have received intramuscular BoNT-A prior to beginning
the study will have their baseline assessments postponed
until one month after their standard follow up has been
completed (approximately 10–12 weeks post injection).
Questionnaires will record the type, frequency and dur-
ation of any concurrent therapies provided by public
and private services during the study for all participants.
Randomisation
Participants will be matched in pairs according to
age (18 month age bands) and intelligence quotient (IQ)
of ≤80 or >80 (measured on the Wechsler Intelligence
Scale for Children – Fourth Edition) [65]. Where avail-
able an IQ assessment which has been completed greater
than 12 months post injury will be used, otherwise an
IQ assessment will be completed prior to matching.
Each member of the pair will then be randomly allocated
either number “1” or “2” using a computer generated
number table. Treatment allocations will be recorded on
a piece of folded paper inside a sealed, opaque envelopes
and opened (in consecutive order) by independent, non-
study personnel. Allocations will read either: “1: Waitlist
2: Immediate”, or “1: Immediate 2: Waitlist”. After the
randomisation process is complete, study personnel will
be informed of group allocation and information packs
will be sent out to families.
Blinding
Structural and functional MRI data will be qualitatively
analysed by neurologists blinded to group allocation and
order of assessments. Functional MRI training scan
quality will be rated on region of activation, change over
time and patterns of reorganisation. Data on the AHA
and MUUL will be rated from video recordings masked
and randomised.
Adverse events
Any minor or major events associated with intervention
or usual care groups will be screened at 20 weeks by
open-ended questions. Any adverse events or unin-
tended effects detected will be reviewed by the principal
researchers RB, JZ and LM.
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Waitlist n=30 children
Care as usual, Regular OT/PT 
(amount & content monitored)
E
nr
ol
lm
en
t
Baseline measures (T0)
Classifier and predictor variables: Gross Motor Function
Classification System (GMFCS), Manual Abilities 
Classification System (MACS), Edinburgh Handedness 
Inventory, Height, Range of Motion, Stereognosis, Moving 
Two Point Discrimination (M2PD), Texture Tactile  
Perception, Mirror Movements, Wechsler Intelligence Scale 
for Children Fourth Edition (WISC-IV) and study 
questionnaire
Primary Outcomes: Assessment of Motor and Process Skills 
(AMPS) and 30 second repetition maximum (repmax) of 
functional strength exercises
Secondary Outcomes: Assisting Hand Assessment (AHA)
Jebsen Taylor Test of Hand Function (JTTHF)
The Melbourne Assessment of Unilateral Upper Limb Function 
(MUUL)
Executive Function: Score!, Sky Search and Sky Search DT
from the TEA-Ch, Digit Span, Coding, and Symbol Search 
from WISC-IV; Comprehensive Trail Making Test 
(CTMT); Tower of London (TOL); Colour-Word 
Interference Test from Delis-Kaplan Executive Function 
System (D-KEFS); Behaviour Rating Inventory of 
Executive Function (BRIEF)
Test of Visual Perception Skills (TVPS)
Canadian Occupational Performance Measure (COPM) 
Physical Activity Capacity: 6-Minute Walk Test (6MWT), High
Level Mobility Assessment Tool (HiMAT) and Timed Up 
and Go (TUG) test
Psychological Function: Strengths and Difficulties 
Questionnaire (SDQ), Conners 3TM - Parent
Physical Activity Performance: ActiGraph® with activity diary
Activity limitations: MobQues47
Participation: Participation and Environment Measure for 
Children and Youth (PEM-CY), Child and Adolescent Scale 
of Environment (CASE), Child and Adolescent Scale of 
Participation (CASP),
Quality of life (QOL): Kidscreen-52, Child Health Utility 
(CHU-9D), child and parent to complete
Total assessment time = 6 hours (over 2 days)
Neurovascular: fMRI = 1.5 hours
Expect to recruit 75% of eligibleNot eligible or not interested.  
No further contact.
Eligible children: children 8 to 16 years with an acquired brain injury, not due 
to or have had botulinum toxin or surgery within 6 months of baseline or over 
study period. 
Matching for age and IQ, then randomisation
Baseline T0 Assessments (n= 60)
0 weeks
Immediate n=30 children
20 weeks MitiiTM training
(60 hours multi-modal training)
Primary outcome post intervention completion (T1)
20-22 weeks
20 weeks MitiiTM training
(60 hours multi-modal training)
Retention (T2)
Measures as per T1
40-42 weeks
Post intervention (T2)
Measures as per T1
40-42 weeks
Retention (T3)
Measures as per T2
60-62 weeks
A
llo
ca
ti
on
F
ol
lo
w
-U
p
Post intervention and retention outcomes (T1, T2 and T3)
Primary Outcomes: AMPS and 30 second repmax of functional 
strength exercises
Secondary Outcomes: AHA
JTTHF
MUUL
Executive Function: Score!, Sky Search and Sky Search DT 
from the TEA-Ch, Digit Span, Coding, and Symbol Search 
from WISC-IV, CTMT, TOL, Colour-Word Interference 
Test from D-KEFS, BRIEF
TVPS
COPM
Physical Activity Capacity: 6MWT, HiMAT, TUG test
Psychological Function: SDQ, Conners 3TM - Parent
Physical Activity Performance: ActiGraph® with activity diary
Activity limitations: MobQues28
Participation: CASE, CASP
QOL: Kidscreen-52, CHU-9D (child and parent to complete)
Total Assessment time = 5 hours
Neurovascular: fMRI =1.5 hours
Fig. 1 CONSORT Flow chart of the move it to improve it (Mitii™) study
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Study procedure
To account for children’s varying abilities to attend and
concentrate and, to mitigate fatigue the following sched-
uling strategies will be used to maximise data integrity
during baseline and follow up assessments. Families will
be contacted prior to baseline assessments to ascertain
whether they feel their child will need one or two days
to complete assessments. All participants will attend
The University of Queensland, St Lucia campus for all
assessments, minimising travel. Neuropsychological test-
ing will be scheduled first as this requires most attention
and concentration by participants. Regular breaks will be
scheduled for participants between assessments as ne-
cessary at baseline and follow-up appointments. All pri-
mary outcome clinical assessments will be performed
prior to Magnetic Resonance Imaging (MRI). Extra time
will be allocated at the start and end of each day to man-
age any unforeseen complications which may arise (e.g.
travel/time delays and fatigue issues). Participants in the
immediate intervention group will spend an additional
day for Mitii™ training and return home with Mitii™ equip-
ment to begin the 20 weeks intervention. After baseline
assessments (T0), the waitlist group will continue care as
usual for 20 weeks. All participants will then return to
The University of Queensland after 20 weeks for a one to
two day re-assessment (T1). The waitlist group will spend
an additional day for Mitii™ training before returning
home with equipment to commence the intervention. For
each participant data will be collected at Baseline (T0).
The immediate intervention group will have follow up
assessments conducted immediately post-training at 20
weeks (T1) and retention at 40 weeks post-baseline assess-
ments (T2). The waitlist group will have a second baseline
assessment at 20 weeks (T1), post-intervention at 40
weeks (T2) and retention of effects at 60 weeks post-
baseline assessments (T3).
Equipment
The Mitii™ intervention requires no specialist re-
sources. All participants will receive a Microsoft
Kinect®, laptops and pre-paid internet dongles for fam-
ilies who are unable to access a computer and/or
internet at home for the 20 weeks intervention period.
If families experience any technical issues, a study
telemedicine engineer will be available to troubleshoot
any technical difficulties. Step blocks, wobble discs
and weights are also provided to families as an
additional challenge for tasks as they progress through
the program.
Mitii™ intervention
Following occupational therapy, physiotherapy, neuro-
psychology and neurovascular assessments the partici-
pants and their parents will complete the Mitii™ training
in preparation to start 20 weeks of intervention. Firstly,
a therapist will deliver a lecture to explain the back-
ground and purpose of Mitii™, how the program works
(see Additional file 1 for the participant manual) and
motivational strategies to encourage engagement in the
program (see Additional file 2 for child rewards chart).
Children will then receive individualised training in how
to use the Mitii™ program based on their capacity in
baseline assessments. Therapists will select between an
easy, moderate or difficult version addressing unilateral
(right or left) or bimanual UL and LL deficits. A de-
identified Mitii™ account will be created using an alias
profile for each participant which will allow the program
to be downloaded from the internet (https://mitiistora-
ge.blob.core.windows.net/vsdeploy/clickonce/publish.htm)
for each participant. Once the program has downloaded,
the child will then able to log onto the program to
complete their training at home or local environment at
their convenience. The program will be requested to be
completed six days a week for 20 weeks. This will pro-
vide a minimum potential treatment dose of 60 h. The
participant should be appropriately supervised by a par-
ent/guardian (according to their age) to ensure activities
are being completed safely and correctly.
Once the participants and their parents have returned
home, the three virtual trainers (one occupational ther-
apist, one physiotherapist and one neuropsychologist)
will develop an individually tailored program from the
12 available modules including; (1) gross motor or phys-
ical activity (e.g. repetitive sit-to-stand exercises); (2)
combined cognitive and visual perception and; (3) UL
(e.g. moving the UL to solve a mathematic equation)
(See Additional file 3). Modules will be combined in
sequence to make a daily program of approximately 30
min duration. To ensure each participant receives a
similar training program, all daily programs will com-
prise of approximately 40 % gross-motor and 60 %
cognitive-UL training modules.
The three virtual trainers will together evaluate each
participant’s performance on a weekly basis and adjust
module content variables to maintain the program at
an appropriate level of difficulty or intensity to promote
a training effect. Therapists access each participant’s
program remotely via the Mitii™ user interface “Cock-
pit” and can monitor how frequently the participant
has logged into Mitii™, how long they have spent en-
gaged in the program, games that have been skipped
and progress in each module. The complexity of the
modules can be adjusted by increasing or decreasing
the level of difficulty of visual perceptual (images
graded on a colour code system of blue-green-red-
black), cognitive (e.g. increasing the length of a memory
sequence) and motor activities (e.g. reducing the base
of support for balance).
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Motivational strategies
Motivational strategies will be discussed during the ini-
tial Mitii™ training session with families and will include
weekly performance feedback, positive re-enforcement
by parents/guardians and incorporating Mitii™ into the
regular family routine. Each participant will also have
the option of using a rewards chart (child or adolescent
version) broken up into four, five week blocks through-
out the program as an additional motivational strategy
(see Additional file 2 for child rewards chart). The re-
wards chart allows small rewards to be negotiated with
the participants and their parents and/or guardians at
the completion of each stage during the initial Mitii™
training. Program options such as physiotherapists dem-
onstrating aerobic activities that are used during activity
modules and including real-world images in figure
ground, spatial relations, match two images and memory
modules, are more likely to appeal to teenagers will be
incorporated in their programs. One of the three virtual
trainers will be assigned as the main contact for the par-
ticipant and their family and remain in weekly contact.
Families will be contacted weekly (or at the family’s re-
quest) to encourage ongoing engagement in the pro-
gram. Once participants have completed the 20 weeks
intervention they will receive a small reward provided by
study personnel and parents will be asked to complete
an exit questionnaire.
Data management
Data will be recorded and managed through a confiden-
tial online database run through the Queensland
Cerebral Palsy and Rehabilitation Research Centre
(QCPRRC). Participants will also have paper files which
will be de-identified and only contain the participant’s
unique identification code. These files will be stored in a
locked filing cabinet at the QCPRRC separate from files
containing participant demographic and consent infor-
mation. The Mitii™ program, participants’ Mitii™ scores
and training history will be stored on a secure server at
the Microsoft Azure Data Centre in Ireland. In addition
to Microsoft’s standard data procedures, the Mitii™ pro-
gram and associated data will be backed up every two
weeks. To ensure participants’ confidentiality, partici-
pants will not have personal information or details
recorded on the program. Participants will use a non-
identifying “alias” name to log into Mitii™ and study
personnel will use their personal email (not linked to the
Mitii™ program) for correspondence.
Classification measures
Australasian Rehabilitation Outcome Centre (AROC)
impairment codes
Classification of the ABI will be made according to the
AROC impairment codes [64]. The AROC impairment
codes describe the reason for rehabilitation according to
impairment groups. Episodes are classified according to
the primary reason for the current episode of rehabilita-
tion care. In total, there are sixteen impairment groups.
Two groups relate to rehabilitation episodes for children
with ABI – Stroke and Brain Dysfunction. Firstly, the
Stroke impairment group can be subdivided into two
sub-groups, “Haemorrhagic” and “Ischaemic”. These
sub-groups are then further subdivided into individual
group codes. Secondly, Brain Dysfunction can be divided
into two sub-groups including, “Non-traumatic” and
“Traumatic”. Non-traumatic brain dysfunction codes in-
clude subarachnoid haemorrhage (2.11), anoxic brain
damage (2.12) and other non-traumatic brain dysfunc-
tion (2.13). Examples of other non-traumatic brain dys-
function include brain injury as a result of tumour,
encephalitis or complications of ventriculoperitoneal
shunt revisions. Traumatic brain dysfunction codes can
be open (2.21) or closed injury (2.22). A rehabilitation
consultant from QPRS will classify all participants ac-
cording to these impairment codes.
Classification of the brain lesion
The nature of the brain lesion will be classified on sMRI
using both a qualitative description [66] and semi-
quantitative scale for classification of brain lesion sever-
ity for children with ABI [67, 68].
Structural MRI will be obtained for each child using
a 3 Tesla (3T) Magnetom (Siemens) scanner using T1-
weighted high resolution 3D MPRAGE, T2-weighted
FSE and 3D FLAIR sequences. Structural MRI will be
evaluated by a paediatric neurologist (SF who will be
blinded to clinical and medical history) to describe the
type of lesion and presumed pathogenic pattern (e.g.
stroke, hypoxia/anoxia, toxic, metabolic or infective in-
juries and head trauma).
The brain lesion severity will be determined by using a
semi-quantitative scale designed for classification of
brain lesion severity in children with CP [67]. The semi-
quantitative scale has demonstrated high inter-rater and
intra-rater reliability [67]. According to the scoring sys-
tem, the brain lesion is represented on a graphical tem-
plate and raw scores for lobes, subcortical structures
(basal ganglia, thalami and brainstem), corpus callosum
and cerebellum are systematically calculated, where
higher scores represent more severe pathology. Each
hemispheric score (HS) is the sum of the lobar scores
(maximum score of 12). The basal ganglia and brainstem
score (BGBS) is the sum of left and right subcortical
structures (basal ganglia, thalamus, brainstem and pos-
terior limb of the internal capsule) (maximum score of
10). The global score (GS) is the sum of the right and left
HS, BGBS, corpus callosum and cerebellum scores (max-
imum of 40). A laterality index (LI) will be calculated for
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each scan (range 0–1) to determine the lateralisation of
the lesion, assuming the HS as the lateralised measure. A
score approximating 0 indicates a more bilateral lesion; a
score approaching 1 more unilateral involvement. Prelim-
inary to further analysis, reliability will be tested in chil-
dren with an ABI.
Classification of brain injury severity
Where possible, available information will be collected
from the participant’s medical records regarding their
initial brain injury as these may have a prognostic effect.
Information will include Glasgow Coma Scale (GCS) at
the time of injury or admission; in the instance of a TBI
length of Post Traumatic Amnesia (PTA), loss of con-
sciousness (LOC) and duration of coma; treating hos-
pital and length of hospitalisation; additional injuries or
complications at time of injury and the Functional Inde-
pendence Measure for Children (WeeFIM) at the time
of discharge [69–71].
A description of comorbidities (e.g. orthopaedic injury,
epilepsy, psychological and pre injury status) and any
other treatments and interventions (e.g. surgical, medical
or radiation) will be collected on an entry questionnaire
completed by the parent. Information regarding the par-
ticipant’s school grade and involvement in a special edu-
cation program will also be collected in the same
baseline questionnaire.
Gross Motor Function Classification System (GMFCS)
The GMFCS for children with CP classifies how children
perform self-initiated movements based on sitting (trun-
cal control) and walking across a five levels [72]. Con-
struct validity has been obtained with a correlation
between the GMFCS and the Gross Motor Function
Measure (GMFM) of r = 0.91 [72]. The measure also has
good inter observer reliability between professionals and
professionals and parents in children with CP [73]. This
classification measure has not been validated for use with
children who have an ABI however it is expected that all
children in the sample will be equivalent to a GMFCS I
(walks without limitations) or II (walks with limitations).
Children will be classified by a physiotherapist.
Manual Abilities Classification System (MACS)
The MACS is a five level classification of how well chil-
dren with CP use their hands to handle objects in day-
to-day activities [63]. The MACS has reported construct
validity and excellent inter-rater reliability (Intra-class
correlation coefficients [ICC] = 0.97 between therapists
and ICC = 0.96 between therapists and parents) for chil-
dren with CP [74]. This scale has not been validated for
children with an ABI however, it is expected that all chil-
dren included in this study will be equivalent to MACS
level I (able to handle objects easily and successfully),
level II (able to handle most objects but with somewhat
reduced quality and/or speed of achievement so that
alternate ways of performance might be used) or level III
(handles objects with difficulty; needs help to prepare
and/or modify activities). Children will be classified by
an occupational therapist.
Edinburgh Handedness Inventory
During baseline assessments, hand dominance will be
assessed using the The Edinburgh Handedness Inventory
[75]. The Edinburgh Handedness Inventory question-
naire consists of 10 items regarding hand preference
(right or left) in performing a number of everyday tasks
requiring one (writing, drawing, throwing and using
scissors) or two (e.g. using a broom or opening a box)
hands. A laterality quotient is calculated using the fol-
lowing formula: laterality quotient = (right hand – left
hand/(right hand + left hand)*100).
Passive Range of Motion (ROM)
Passive ROM for the unimpaired and impaired side will
be assessed by the same occupational therapist (UL) and
physiotherapists (LL) at baseline only to determine any
relevant impairments (e.g. joint contractures) which may
limit access to the program and inform participation in
the study.
Sensory measures
Three different descriptive, sensory measures will be
obtained from participants at baseline by an occupa-
tional therapist:
I. Stereognosis will be assessed on the non-dominant
and dominant hands using the approach described
by Feys [76]. Three familiar objects (teaspoon, key
and peg) and six similar matched objects (safety pin
and paperclip; pen and pencil; coin and button) will
be used. With vision occluded, participants will be
presented with each item. If a participant is unable
to grasp, manipulate or release an object the
occupational therapist will assist the participant
and move the object for them within their hand.
A corresponding set of items will be used to allow
participants to identify the object in order to
minimise any errors due to incorrect naming of the
object. Scores range on a scale from 0–9, where
participants scoring below 9, will be considered to
have impaired stereognosis [77].
II. Moving two point discrimination (M2PD) will be
measured using the Disk-criminator® (Baltimore,
Maryland) on both the non-dominant and dominant
hands. Either one or two points will be randomly
applied in continuous moving firm contact longitu-
dinally to the pulp of the index finger with vision
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occluded [78]. The minimum distance participants
can usually distinguish between two discrete points,
ranges from 2mm (normal) to 15 mm (poor) [79].
III. Texture Tactile Perception will be tested using the
AsTex Perspex board that displays tactile gratings
of reducing tactile discrimination index [80].
Starting at the “rough” end of the board, movement
of the participant’s index finger, then thumb, then
fifth finger will be guided by the examiner along the
board at a constant speed in a standardised manner.
Participants will be instructed to stop immediately
when the board feels smooth (gratings become too
close together to determine their separation). Each
point will be recorded, with the final outcome the
average of three trials for each digit. The average
scores will be converted to the tactile discrimination
index for each finger using the chart available with
the test kit.
Mirror movements
The presence of mirror movements will be assessed (by
an occupational therapist) and scored on the side of the
body unintentionally performing the movement during
three unimanual UL tasks: (i) rapid tapping of the index
finger on the distal thumb, (ii) alternating supination
and pronation of the forearm and (iii) repetitive alternate
touching of each fingertip to the tip of the thumb of the
same hand, in order. Participants will be scored on a
four point scale ranging from no clearly imitative move-
ments, to movement equal to that of the intended hand.
Possible total score range is from 0–12 [81].
Grip strength
Grip strength will be measured using a hand held dyna-
mometer (Smedley®, Scientific Instruments Co Ltd) by
an occupational therapist. Grip strength will be mea-
sured for three attempts on each UL (kilograms force,
Kgf ) according to the guidelines of the American Society
of Hand Therapists [82]. The mean of the three attempts
will be used to compare limbs and to evaluate changes
over time.
Anthropometric data
Height will be measured to the nearest 0.5 cm while the
participant is standing with his or her back against a wall
with a ruler. Body Mass Index (BMI) will be collected at
baseline only. This will be used to convert activity cap-
acity tests into referenced percentiles.
Wechsler Intelligence Scale for Children–Fourth Edition
(WISC-IV)
Overall level of cognitive intellectual functioning will be
assessed using the WISC-IV [65]. The WISC-IV consists
of ten subtests that make up the four indices of verbal
comprehension (VCI), perceptual reasoning (PRI), work-
ing memory (WM), and processing speed (PSI). A full
scale intelligence quotient (FSIQ) score can be calculated
from these index scores. The VCI index is made up of the
Vocabulary, Comprehension and Similarities subtests. The
Vocabulary subtest assesses knowledge of word meaning
and will require participants to name pictures or provide
spoken definitions of words (e.g., “what is a bicycle?”). The
Comprehension subtest measures verbal reasoning and
conceptualisation and demonstrates practical information.
The Similarities subtest assesses verbal abstraction and
reasoning and will require participants to describe how
two words are similar (e.g., “how are anger and joy alike”).
The subtests of Block Design, Picture Concepts and
Matrix Reasoning make up the PRI index. Block design
will require participants to construct abstract visual de-
signs using a set of red-and-white three dimensional
blocks within a specified time period. Picture Concepts is
designed to measure nonverbal abstract, categorical rea-
soning ability. For Matrix Reasoning, participants will be
shown an array of visual designs with one missing square.
They will be required to use their non-verbal abstract rea-
soning and problem solving skills in order to select the
correct picture from an array of five options that fits into
the missing space of a visual design. The WMI index is
made up of the Digit Span and Letter-number sequencing
subtest. For the Digit Span subtest, participants will be
required to repeat a number of verbally presented digits in
both the forward and reverse order. The Letter-number
sequencing subtest will require participants to sequence
letters and numbers in order which involves sequencing,
mental manipulation, attention and short term auditory
memory. Finally, the PRI index is made up of the Coding
and Symbol Search subtests. For the Coding subtest, par-
ticipants will need to match up abstract symbols with
numbers from a key and for Symbol Search, participants
will be required to detect the presence of one or more
symbols in a sequence of five. These subtests have a two-
minute time limit and therefore require participants to
work as quickly as possible without making mistakes [65].
Raw scores from the subtests can be converted into
scaled scores with a mean of 10 and standard deviation
(SD) of three using age and gender appropriate norma-
tive data. Index scores can be converted into composite
or scaled scores with a mean of 100 and SD of 15. The
VCI, PRI and WMI and FSIQ index scores of the WISC-
IV demonstrate very high levels of internal consistency
(α > 0.90). The PSI index has high internal consistency
(α = 0.80-0.89) [65].
Neurovascular measures
Whole-brain fMRI studies
All participants will be checked for 3T MRI safety includ-
ing no metal implants or ventriculoperitoneal shunts.
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Participants will be prepared in the mock MRI scanner
prior to the real scan to familiarise them with the
image procedure and minimise the potential for psy-
chological distress.
Functional imaging at 3T on a Siemens MAGNETOM
Trio MRI scanner will be conducted on the research
dedicated scanner at The University of Queensland,
Centre for Advanced Imaging (CAI), Brisbane, Australia.
Published methods will be utilised for conducting serial
functional MRI (fMRI) studies including preparation in a
mock MRI scanner and assessing activation during a
range of tasks as outlined below. Two of three tasks will
be performed, depending on age and motor abilities:
(i) All participants will perform a simple wrist flexion/
extension movement task in a two-condition block
design, visually cued via instructions projected on a
screen. The baseline condition is no movement
(rest). A recording of a metronome at two hertz will
provide an auditory cue for the rate of movement.
Participants will be required to flex and extend the
wrists of each hand one at a time, in time with
metronome and lie still with no movement during
the baseline blocks. The task and rest periods are 30
s with the activation cycle repeated four times. The
movements performed in the scanner will be rated
for speed, ROM, ability to isolate the movement and
presence of mirror movements in the contralateral
hand. If there is task-correlated breath-holding, the
task will be repeated.
(ii) Older participants and those with sufficient fine
control in the least impaired hand will also perform
a complex movement sequencing task, aimed at
examining function in higher motor areas and basal
ganglia circuits. In this task, visual cues will indicate
a sequence of three button-presses to perform (e.g.
132; sequence condition), or three simple repetitive
presses with the index finger only (e.g. 111; simple
condition). The task will be run in blocked design,
with 20 s of simple, 20 s of sequence, and 20 s rest
blocks in counterbalanced order for a total scan
duration of six minutes.
(iii)For examination of visuo-spatial processing and
spatial working memory, a mental rotation task will
be used [83]. For each trial, participants will be pre-
sented with a single target stimulus above fixation
and two-test stimuli below, on the visual display.
Participants will be required to indicate by button-
press which test stimulus matches the target.
Mental rotation stimuli are Shepard–Metzler
three-dimensional cube objects, with target and test
stimuli differing by 30° or 60° rotation (two dimen-
sional rotation only), as used previously in children
of the same age range [83]. In a baseline condition,
participants must indicate which of two spatial
Fourier-transformed ‘noise’ patches is the best visual
match to the target. Stimuli are presented for 10 s
with one second inter-stimulus interval. Groups of
three baseline trials alternating with three rotation
trials (forming 33 s blocks) are presented in 12
blocks over a total scan duration of six minutes and
36 s. The mental rotation task is similar to match-
ing puzzle pieces, which some children may find
interesting. The mental rotation task has been
performed in paediatric populations with Attention
Deficit Hyperactivity Disorder (ADHD) [83]. As the
mental rotation task is quite different to the current
battery of occupational therapy and neuropsycho-
logical tests, children will perform the task both
inside and outside the scanner to compare
performance and account for practice effects.
An additional five minutes of resting-state fMRI
will also be collected for analysis of FC. Tasks
performed prior to resting-state fMRI can
influence FC so the resting-state data will be
collected after the motor paradigms [84].
For all tasks, fMRI will be acquired using a BOLD ac-
quisition sequence (Gradient-recalled-echo [GRE] Echo-
Planar Imaging [EPI], Repetition Time [RT] = 3.0 s, Echo
Time [ET] = 30 milliseconds, flip angle = 850, slice thick-
ness = 3 mm, Field of View [FOV] =216 mm, 44 slices,
72 × 72 matrix yielding an in-plane resolution of 3.0
mm × 3.0 mm). A single set of T2-weighted anatomical,
FLAIR and 3D T1 (MPRAGE 1mm isotropic resolution)
volumes will also be collected. Functional MRI image
processing, analysis and visualisation will be performed
using SPM software (Welcome Department of Imaging
Neuroscience, London, UK).
Diffusion imaging acquisition and white matter fibre
tracking
Diffusion-weighted images will be acquired using a
twice-refocused single-shot EPI sequence (64 directions,
B-value = 3000 s per millimetre squared (s/mm2), con-
tiguous slices with whole-brain coverage at 2.2 mm
isotropic resolution, acquisition time approximately 10
min). White-matter tractography will be undertaken in a
manner robust to crossing fibres, using constrained
spherical deconvolution (CSD) and probabilistic stream-
lines using MRtrix software [85–87].
To improve the understanding of cortical plasticity
post-intervention, cortical reorganisation will be investi-
gated using a combined fMRI-probabilistic tractography
approach. White matter connectivity maps will be pro-
duced using MRtrix by seeding every brain voxel and
using regions of corticomotor activation generated post-
intervention as target masks for the tracking algorithm.
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This will enable identification of all cortical regions, which
have white matter tracts that directly project into cortico-
motor regions exhibiting plasticity as a result of the motor
training paradigms. By comparing connectivity maps pre
and post-intervention (registered within the same image
space), this strategy enables both an anatomical view of
cortical reorganisation and quantitatively analyses altered
connectivity by measuring the number of streamlines con-
necting two cortical regions, corrected for brain size. The
basis of this strategy has recently been published in Neu-
roimage [88]. It is hypothesised that increased intrahe-
mispheric and interhemispheric connectivity showing
recruitment of additional corticomotor areas will dir-
ectly correlate with improved motor function [88]. The
HARDI paradigm for this cohort of children is the same
as previously conducted at CAI in the Mitii™ CP and
CoMBIT protocol studies [89, 90].
Nine typically developing children will also be re-
cruited as a reference sample for the neuroimaging stud-
ies. Children will be recruited through staff newsletters
and from other studies within the centre. Five children
will complete all tasks involved for fMRI, sMRI and
dMRI. Four children will only complete sMRI and men-
tal rotation tasks.
Primary outcome measures
Assessment of Motor and Process Skills (AMPs)
The AMPs assesses the quality of performance of an
individual engaged in culturally relevant personal or in-
strumental ADL. It is a standardised, criterion-referenced,
observational assessment that can be used for children
from two years of age [91]. An interview is conducted with
the child and the therapist selects appropriate familiar
tasks from 116 task options. The participant performs a
minimum of two daily activities (e.g. dressing, eating, and
food preparation). A trained occupational therapist will
evaluate the participant’s performance on degree of exer-
tion, efficacy, confidence and independence for 16 ADL
motor and 20 ADL processing skills, as well as overall
functioning levels. Performance in each of the motor and
processing skills will be scored from 1–4 (1 = deficient
performance that impeded the action progression and
yielded unacceptable outcomes, to 4 = competent per-
formance that supported the action progression and
yielded good outcomes). Computer-scoring software will
be used to convert raw scores into linear ADL motor and
ADL process ability measures through many-faceted
Rasch analyses. Scores range from +4 to −3 for motor
skills and +3 to −4 for processing skills. Test-retest reli-
ability of the AMPS is high for both motor (ICC = 0.93;
95 % CI = 0.86-0.97) and process (ICC = 0.86, 95 % CI =
0.65-0.94) skill scales in children with CP [92]. The mini-
mum detectable change was found to be 0.23 logits for
the AMPS motor scale and 0.30 for the AMPS process
scale [92]. This measure is also very sensitive to change,
as it evaluates the smallest possible units of ADL task
performance and involves 116 task options which vary in
challenge. Participants will have the option to participate
in test-retest reproducibility, carrying out the AMPS over
two consecutive assessment days with a trained occupa-
tional therapist.
Lower Limb (LL) functional strength
Thirty second repetition maximum (repmax) of func-
tional strength exercises (including sit-to-stand, lateral
step-ups and half-kneel to stand) will be tested accord-
ing to published recommendations [93]:
Sit-to-stand: This test measures the ability of the
participant to attain standing (from 90° knee flexion) as
many times as possible in 30 s with arms free or placed
on their hips and without support from the chair or
their body. Height of the chair will be defined by the
ability of the participant to attain 90° hip and knee
flexion with feet flat on the floor. One repetition will be
defined as each time the participant is within 15° of hip and
knee extension, visually estimated by a physiotherapist.
Lateral Step-Up: The aim of this test is to perform as
many step up repetitions onto a 20 cm step block as
possible in 30 s. Participants will be asked to stand with
the foot being tested on the step and the non-test leg on
the floor, parallel and shoulder width apart. The partici-
pant then raises the non-test foot off the ground until
the test leg has reached within 10° of knee extension
(visually estimated) for the tested foot during the exten-
sion phase of the test. The non-test foot does not have
to touch the step block. Repetitions will be counted each
time the heel or toes of the foot not being tested touches
the ground. Both legs will be tested with the dominant
leg tested first.
Half-kneel to Stand: This activity tests the ability of
participants to attain a stride stance through a half-kneel
position without the use of arms for as many repetitions
that can be completed in 30 s. The participant is placed
in half-kneel with buttocks clear of the lower legs and
floor. The participant will be instructed to assume a
standing position within 15° of knee extension (visually
estimated) and remain with their feet apart (one repeti-
tion). This is a slight adaptation to the original protocol
where participants assumed a standing position with feet
together. The dominant leg in front will be tested first
and repeated for the non-dominant side.
For each LL functional strength exercise participants
will be given verbal and visual instructions as well as
two practice repetitions prior to testing. The exercises
will be assessed in the following order: (i) Sit-to-stand,
(ii) Lateral step-up dominant, (iii) Lateral step-up non-
dominant, (iv) Half-kneel to stand dominant and (v)
Half-kneel to stand non-dominant and participants will
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be given verbal encouragement throughout. Participants
will be given 180 s rests between exercises. If a partici-
pant cannot complete an exercise whilst performing the
practice attempts, they will be assigned a score of 0 and
will not proceed to testing.
Functional strength tests demonstrate acceptable
inter-tester reliability (ICC= > 0.91; coefficient of vari-
ation (CV) 12.1-22.7 %) in 25 children with CP [93].
Reliability for each of these three tests was also strong
(Lateral step up ICC = 0.94; Sit to stand ICC = 0.91;
Half kneel to stand ICC = 0.93-0.96) [93]. Mean repeti-
tions for each of the functional measures were as fol-
lows: (i) sit-to-stand was 14.4 (SD = 5.0; Standard error
of measurement [SEM] = 1.5 reps; CV = 12.1 %), (ii)
lateral step up left were 13.2 (SD = 10.5; SEM = 2.4
reps; CV = 17.8 %), (iii) Lateral step-up right was 12.6
(SD = 10.4; SEM = 2.6 reps; CV = 22.7 %), (iv) Half-
kneel to stand left was 7.5 (SD = 5.5; SEM = 1.1 reps;
CV = 28.6 %), (v) Half-kneel to stand right was 6.0
(SD = 5.3; SEM = 1.4 reps; CV = 39.9 %) [93].
Secondary outcome measures
Body structure and function domain
Jebsen Taylor Test of Hand Function (JTTHF)
Upper limb manual speed and dexterity will be mea-
sured using the JTTHF [94]. Six timed tasks of varying
complexity using everyday items requiring grasp and re-
lease ability will be performed on each UL. The domin-
ant hand will be tested first, followed by the non-
dominant hand. In accordance with previously published
modifications to the administration of the JTTHF, the
writing task will be omitted. The maximum allowable
time to complete each item will be capped at two mi-
nutes to reduce frustration [95–97]. The JTTHF is re-
sponsive to change due to UL intervention although
there have been questions raised about the stability of
test-retest performance in the unimpaired limb [95–98].
Inter-rater reliability for each subtest is high (ICC =
0.82-1.0).
The Melbourne Assessment of Unilateral Upper Limb
Function (MUUL)
Quality of UL movement will be evaluated using the
MUUL [99]. The MUUL was designed for children with
neurological impairment aged 5–15 years and comprises
16 criterion-referenced items measuring movement
range, accuracy, dexterity and fluency. The maximum
possible raw score is 122. Raw scores will be converted
and reported as percentage scores (higher scores repre-
sent greater quality of movement). Total test scores have
very high levels of inter-rater (ICC = 0.95), intra-rater
(ICC = 0.97), and test re-test reliability (Concordance
Correlation of 0.98). Construct, content and criterion
validity for the MUUL have been established [99–101].
The MDC has been estimated in a number of studies
ranging from 7.4 to 14 % [99, 102, 103]. The MUUL has
recently undergone revision. Rasch analysis did not
support uni-dimensionality of the MUUL. The revised
version comprised 14 items that are organised in four
separate sub-scales [104]. The original version of the
MUUL will be used in this study as evidence for the
revised version is preliminary.
Executive functioning
Executive functioning will be evaluated using a compre-
hensive neuropsychological test battery which was de-
signed to assess the four domains of executive functioning
in accordance with Anderson’s paediatric model of execu-
tive functioning [13]. The four domains are attentional
control, information processing, cognitive flexibility and
attentional control. The neuropsychological test battery
consists of subtests from the Delis-Kaplan Executive
Function System (D-KEFS) [105], Test of Everyday Atten-
tion For Children [106], the Wechsler Intelligence Scale
for Children Fourth Edition (WISC-IV) [65], the Compre-
hensive Trail Making Test (CTMT) [107] and the Tower
of London – Second Edition [108]. The Behaviour Rating
Inventory of Executive Function (BRIEF) [109], a parent-
rated questionnaire will be used as a measure of behav-
ioural manifestations of executive functioning in everyday
life. All scores will be converted into scaled scores using
age and gender based norms.
i) Colour-Word Interference Test (from the D-KEFS)
The inhibition condition of the Colour-Word Interfer-
ence subtest of the D-KEFS will be used as a primary
measure of attentional control. The subtest measures an
individual’s ability to suppress an automatic response in
favour for an abstract one. Participants will be assessed
on their ability to name the colour of the ink colour
words that are printed across five rows (e.g. say “blue”
for the word “red” that is printed in blue ink). Partici-
pants will be timed (in seconds) on how long it takes
them to complete the task as well as how many mistakes
they make. Raw scores are converted into scaled scores
(M = 10, SD = 3) using normative data provided in the
manual. The Colour-Word Interference subtest of the
D-KEFS has demonstrated excellent test-retest reliability
(r = 0.90) [105].
ii) Comprehensive Trail Making Test (CTMT)
Trails one, two and three from the Comprehensive
Trail Making test will be used to measure attentional
control and trails four and five will be used to measure
cognitive flexibility in children with an ABI. In trails one
to three, participants will connect numbers printed on
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an A4 sheet in numerical order from 1–25. Distractor
items are contained in trails two and three to increase
the need for attentional control. In trail four, participants
will draw a line in order connecting the numbers 1–20.
The numbers are presented in both Arabic numerals
(e.g. 1, 7) and numbers spelled out in the English lan-
guage form (e.g. Nine). Lastly, for trail five, participants
will be required to switch back and forth between con-
necting numbers in numerical order and letters in alpha-
betical order, also printed on an A4 sheet, from 1–13,
and A – L (e.g. “1-a-2-b-3-c”). The total time (seconds)
taken to complete each trail will be recorded, with a lon-
ger time indicating greater difficulty with attentional
control or cognitive flexibility. Raw scores will be con-
verted to T-scores (M= 50, SD = 10). Good internal test-
retest reliability has been shown for the five trails (r =
0.70–0.78) [107].
iii)Tower of London (TOL) – Second Edition
The Tower of London will be used to measure goal
setting. Participants will move three coloured beads
across three vertical pegs on their board varying in
height to build a target tower on the examiner’s identi-
cal board, within a specified time limit. There are 10
problems of increasing difficulty. They will be instructed
to use the least number of moves possible to complete the
tower, that they can only move one bead at a time and that
they must not put more beads on a peg than it will hold
(e.g. the second peg can only hold two beads and the third
peg can only hold one bead). The total move score, which
is based on the total number of moves needed to build
each of the 10 towers; the total correct score which is the
number of towers correctly solved in the recommended
moves; and the total rule violations will be used to meas-
ure goal setting abilities. The lower the total move score
and total correct score, and the higher the total rule viola-
tions score indicate greater goal setting difficulties. Raw
scores will be converted into standard scores (M= 100,
SD = 15). The Tower of London has adequate test-retest
reliability (r = 0.28–0.75) [108].
iv)Digit Span (from the WISC-IV)
As explained previously, the Digit Span subtest from
the WISC-IV is a verbal memory task where children
are required to repeat a number of digits in the forward
and backwards order. Digit Span Forward is a measure
of a child’s ability to temporarily store information. The
examiner will say a string of numbers increasing from
two digits to nine, and the participant is required to
repeat them back. Digit Span Backwards, is similar but
instead of repeating the string of numbers in the same
order as presented, the child is required to repeat the
string of numbers in the reverse order (e.g. if “5-7-4”,
the child should say “4-7-5”). Digit Span Backward is
also a measure of a child’s ability to temporarily store
information but they are also required to mentally ma-
nipulate in working memory too. As such, Digit Span
Backwards will be used as a measure of cognitive
flexibility. Children are given a score of one for every
number string they repeat correctly in reverse order.
This means lower overall scores for Digit Span Backwards
will indicate poorer cognitive flexibility. Raw scores are
converted into scaled scores (M = 10, SD = 3) using nor-
mative data provided in the manual. Internal consistency
for Digit Span Backwards was good (α = 0.80) and it also
has adequate test-retest reliability (r = 0.74) [110].
v) Coding (from the WISC-IV)
The Coding subtest from the WISC-IV will be used as
a measure of information processing. Participants will be
required to match up and copy abstract geometric
shapes with numbers from a key within a two minute
period. Participants will be scored based on the number
of correctly copied abstract geometric shapes within the
time limit. Lower numbers will ultimately indicate poor
information processing abilities. Raw scores will be con-
verted into scaled scores (M = 10, SD = 3) using norma-
tive data provided in the manual. Coding has been
shown to have a good internal consistency (α = 0.82) and
test-retest reliability (r = 0.81) [110].
vi) Symbol Search (from the WISC-IV)
The Symbol Search subtest of the WISC-IV is also
used as a measure of information processing. In a two-
minute time limit, participants will be required to visu-
ally scan for target symbols in groups of five symbols
and indicate whether the target symbol is in the group
by placing a line through the word ‘yes’ or ‘no’. Partici-
pants will be scored based on the total number of cor-
rectly identified symbols minus the total number of
incorrectly identified symbols. Lower scores on Symbol
Search indicate poorer information processing. Raw
scores will be converted into scaled scores (M= 10, SD = 3)
using normative data provided in the manual. Symbol
search has adequate internal consistency (α = 0.79) and a
high level of test-retest reliability (r = 0.80) [110].
vii) Brief Rating Inventory of Executive Function (BRIEF)
As indicated, the BRIEF is a parent-rated question-
naire designed to assess the behavioural manifestations
of executive functions in everyday life. Parents will be
required to rate 85 items (e.g. “becomes upset with
new situations”) on a three-point likert scale ranging
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from 1 (never) to 3 (often). Raw scores will be converted
into T scores (M = 50, SD = 10) using normative data
provided in the manual. The BRIEF consists of eight
subscales which combine to form the Behavioural
Regulation Index (BRI; Initiate, Working Memory,
Plan/Organise, Organisation of Materials and Monitor
subscales) and the Metacognition Index (MCI; Inhibit,
Emotional Control, and Shift subscales). These inturn
form the overall Global Executive Composite (GEC).
Elevations on subscales and indices will be determined
by a T score of 65 and above, which is 1.5 SD above the
mean. Higher T scores indicate progressively greater
levels of executive dysfunction. The BRI, MCI and GEC
indices will be used as primary measures of executive
function in everyday life. The BRIEF has been shown to
be a valid measure of executive functioning and has
good internal consistency (α = 0.80-0.98) and high test-
retest reliability on the BRI (r = 0.92), MCI (r = 0.88),
and the GEC (r = 0.86) [109].
Attention
Attention will be measured by using the Test of Everyday
Attention for Children (TEA-Ch) [106] and the parent
rated questionnaire the Conner’s 3rd Edition. Selected sub-
tests from the TEA-Ch will be used and are described
below.
Test of Everyday Attention for Children [106]
viii)Score! (TEA-Ch)
Sustained attention will be assessed using Score!. Par-
ticipants will be required to keep a count of the number
of ‘scoring’ sounds they hear on a tape, as if they were
keeping the score on a computer game across several tri-
als. Due to the ceiling effect in this test, correlations are
unrealistic therefore there is 76.2 % agreement within
one SD for test-retest [106].
ix)Sky Search (TEA-Ch)
Selective/focused attention will be assessed using
Sky Search. This is a brief, timed subtest. Participants
will be required to circle as many ‘target’ spaceships as
possible on an A3 sheet filled with very similar distrac-
ter spaceships. In the second part of the task there are
no distracters. Subtracting part two from part one
gives a measure of a child’s ability to make this selec-
tion that is relatively free from the influence of motor
slowness. Sky Search has high test-retest reliability
(r = 0.80 for time-per-target and r = 0.75 for attention
score) [106].
x) Sky Search DT (TEA-Ch)
Sustained attention will be assessed using Sky Search
Dual Task (DT). This subtest combines the sustained
attention task of counting ‘scoring’ sounds (Score!) with
the selective/focused attention task of Sky Search. Par-
ticipants will be required to circle as many ‘target’ space-
ships as possible on the A3 sheet at the same time as
counting the number of ‘scoring’ sounds on a tape. Sky
Search DT has high test-retest reliability (r = 0.81) [106].
Conners 3rd Edition™ (Conners 3™)
The Conners 3™ [111] is a thorough assessment of
ADHD and its most common co-morbid problems and
disorders in children and adolescents ages 6–18 years
old. The Conners 3™ will be completed by the partici-
pant’s parents or guardian and consists of 110 state-
ments and takes approximately 20 min to complete.
Parents or guardians must rate each statement using a
four-point scale ranging from ‘0 – Not true at all (never,
seldom)’ to ‘3 – Very much true (very often, very fre-
quently)’. The Conners 3™ measures the seven key areas
of inattention, learning problems, aggression, family rela-
tions, hyperactivity/impulsivity, executive functioning
and peer relations. Raw scores are converted into T
scores based on a large representative normative sample
based on United States of America consensus data. In
addition, the Conners 3™ calculates T scores for symp-
tom scales including ADHD Hyperactive/Impulsive,
ADHD Combined, Oppositional Defiant Disorder,
ADHD Inattentive and Conduct Disorder. Both internal
consistency coefficients (α = 0.83–0.94) and test-retest
reliability (r = 0.52–0.94) are good for the Conners 3™
Parent version total sample age range [111].
Test of Visual Perceptual Skills (TVPS)
The TVPS assesses visual-perceptual strengths and
weaknesses on seven subtests (visuo-spatial relation-
ships, visual discrimination, visual memory, visual se-
quencing memory, visual closure, visual constancy and
visual figure ground) each with developmentally incre-
mented items. Performance will be determined by num-
ber of correct answers in each test (maximum of 16 in
each of the seven tests). Raw scores will be scaled and
converted into percentage score for the age group based
on normative data [58]. A systematic review of visual
perception tools of children with hemiplegia, found
strong test-retest reliability for total TVPS scores [112].
Activity capacity domain
6-Minute Walk Test (6MWT)
The 6MWT is an objective, submaximal evaluation of
functional exercise capacity. It reflects an exercise level
close to that of daily life activities. This test measures
the distance that a patient can quickly walk on a flat,
hard surfaces in a six minute period (the 6MWD) [113].
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The 6MWT will be performed using a 10 m track with
cones demarcating the turning points [114]. Participants
will be given verbal and visual instructions (physiotherap-
ist will demonstrate one lap) before testing. Participants
will be instructed to “Walk as far as possible without run-
ning in six minutes, completing as many laps as you can.
Make sure you walk around the cones”. Participants will
be instructed not to talk throughout the test. Participants
will be given verbal encouragement, and every 30 s will be
advised of the distance covered (in laps) and the time
remaining. Distance will be measured to the nearest five
metre mark.
The 6MWT is responsive, valid and reliable in chil-
dren with CP and adults with TBI [115–117]. No psycho-
metric data exist for Australian children and adolescents
with an ABI, however it is expected children with an ABI
will perform similarly to children with CP.
High-Level Mobility Assessment Tool (HiMAT)
The HiMAT was specifically developed to measure high-
level motor performance in adults with TBI [118, 119].
This uni-dimensional measure consists of 13 items that
assess high-level walking tasks, the ability to negotiate
stairs, run, skip, hop and bound. This tool is used in
both clinical and research settings. The test has reported
high inter-rater (ICC = 0.99), test-retest reliability (ICC =
0.99, MDC = −2 to +4) and internal consistency (Cron-
bach alpha = 0.97) in adults with moderate and severe
TBI [120]. Concurrent validity was established with the
motor subsection of the Functional Independence Meas-
ure instrument and the gross function component of the
Rivermead Motor Assessment, demonstrating moder-
ate (r = 0.53, p < 0.001) and strong correlations (r =
0.87, p < 0.001), respectively [121]. Psychometric prop-
erties, including inter-rater reliability (ICC = 0.99),
intra-rater reliability (ICC = 0.95, MDC = −3 to +4), re-
sponsiveness (area under the curve = 0.86) and validity
(significant negative association with the Rivermead
Post Concussion Symptoms Questionnaire, rho = −0.63,
p < 0.001) of the HiMAT have been established in an
adult population with mild TBI [122].
The HiMAT will be performed according to published
recommendations [119]. These guidelines state that test-
ing should take place along a flat, straight corridor
where the middle 10 m of a 20 m track is timed except
for the bounding and stair items. Two cones will be
placed at either end of a 20 m track and video recorders
will be set up at the 5 and 15 m interval. Markers will be
moved to the 5 and 15 m interval for hopping as partici-
pants are only required to hop 10 m. For bounding
items, a tape measure will be placed flat on the floor,
and distance achieved will be measured to the nearest
0.5 cm. For ascending and descending stairs, cameras
will be set-up at the top and bottom of the stairs (total
of 10 stairs, scores adjusted accordingly for 14 stairs). A
rail will be available on the right-hand side, and a wall
on the left going up the stairs. If a participant is not
comfortable ascending or descending stairs using the
wall, participants can hold the physiotherapist’s hand,
with the physiotherapist remaining behind the partici-
pant at all times. Participants will be given verbal in-
structions and one visual demonstration for all items.
Participants will be instructed to perform at their max-
imum safe speed for items along the 20 m track and will
be allowed one practice trial for each item before testing.
Participants will be unaware that only the middle 10 m
will be timed.
Raw scores measured in time and distance (centi-
metres) will be recorded and converted to a score from
0 to 4 where 0 represents the inability to perform an
item, and scores from 1 to 4 represented increasing
levels of ability (for both timing methods). The max-
imum score on the HiMAT is 54 (13 items with a max-
imum converted score of 4, plus one additional point on
each stair item). Timed items in the HiMAT will be
collected using a hand held stopwatch and a video
timing method utilizing two video recorders (except
bounding items).
Video cameras will be synchronised after the HiMAT
has been completed with an auditory output from the
assessor to start each HiMAT component. The 10 m
time will be calculated from when the participant’s LL
crossed the 5 and 15 m mark (as a ratio of distance and
time). Cameras will be placed at the top and bottom of
stair items and cameras will be synchronised again
with an auditory output from the assessor to start.
Time will be recorded from when the participant’s foot
to clears the ground to when both feet are flat on the
ground (ascending or descending stairs). Video record-
ings will be analysed using the video editing software
program (Cyberlink powerdirector 9.0, New Taipei
City, Taiwan) which de-interlaces video files to 25 im-
ages per second.
The Timed Up and Go (TUG) test
The Timed “Up & Go” (TUG) test is commonly used
to quantify functional mobility and balance [123]. The
TUG will follow original published guidelines with
minor variations [124]. A chair with a backrest but with-
out arm rests will be used and the height of the chair
will be selected so that the participant’s feet are flat on
the floor and hips and knees flexed to 90°. During as-
sessment participants will be instructed on the word
“go” to stand up (without using hands) and walk a dis-
tance of three metres, turn around a cone, walk back
to the chair and sit down as fast but as safely as pos-
sible without running. Verbal and visual instructions and
an unrecorded practice trial will be provided. Time will be
Boyd et al. BMC Neurology  (2015) 15:140 Page 18 of 29
recorded as participants leave and return to the chair.
Children will perform three trials and the average will be
recorded. If participants run or deviate from the testing
protocol, they will perform an additional trial.
Participants will be timed using a handheld stopwatch
and a video timing method. The video timing method
involves placing a camera perpendicular to the chair so
it captures time taken for the participant’s ischial tuber-
osity to clear the chair and on return, for the length of
their posterior thigh to make full contact with the chair
when sitting back down. Video recording will be analysed
using the same software program as for the HiMAT
(Cyberlink powerdirector 9.0, New Taipei City, Taiwan).
The TUG test was found to be reliable in Israeli chil-
dren aged 7–14 years with TBI (ICC = 0.86) [125]. Israeli
children at least one year post-severe TBI were found to
perform significantly slower than typically developing
peers on the TUG test. The TUG test is also a valid and
reliable measure in children with CP. The TUG test was
able to discriminate between levels I to III on the
GMFCS (p < 0.001). The TUG test also demonstrated a
moderately negative correlation with the Gross Motor
Function Measure (GMFM) (rho = −0.524, p = 0.012)
with lower TUG scores being associated with higher per-
centages of GMFM scores for the standing and walking
dimensions. Finally, the TUG test has evidence of good
intra-rater and test-retest reliability (ICC = 0.98; 95 % CI =
0.97-0.99 and ICC= 0.83, 95 % CI = 0.77–0.88, respectively)
in children with physical disabilities [126]. Standard Error
of Measurement was on average, 0.5 s [126].
Activity performance domain
Assisting Hand Assessment (AHA)
The AHA is a Rasch analysed measure that evaluates
how a child with a unilateral impairment (congenital
hemiplegia or obstetric brachial plexus palsy) effectively
makes use of his/her impaired UL in bimanual tasks
[127]. The assessment is videotaped and 22 items are
scored on a four point rating scale, with a range of
possible raw scores of 22 to 88. Raw scores will be
converted to interval level AHA units (logits- log odds
probability units on a scale of 0 to 100), as recom-
mended by test developers as the preferred method of
reporting and measuring change [128]. Depending on
the age of the child and in accordance with recommen-
dations from test developers, one of the three versions
of the AHA will be used (the small kids, school kids or
adolescent version). The small kids and school kids ver-
sions have high test re-test reliability (ICC = 0.99 and
0.98 respectively) and reliability between the two forms
is very high (ICC = 0.99). Reliability between the school
kids and Ice Rocks (adolescent version) has not yet been re-
ported, however the adolescent version will be used in this
study for youth over the age of 12 years, as the school kids
version is not valid nor age appropriate for this population.
The AHA has been shown to be responsive to change due
to UL interventions [103, 129, 130]. The MDC is estimated
as five AHA units. Although the AHA is not validated in
children with an ABI, it is expected that they will perform
similarly to children with a unilateral impairment. In ac-
cordance with test recommendations, all therapists admin-
istering the AHA will have undergone standardised training
and certification [127] and will be scored by one certified
rater masked to group allocation and order of assessment.
Habitual Physical Activity (HPA)
HPA will be measured using ActiGraph® GT3X+ triaxial
accelerometer (Shalimar, FL). The ActiGraph measures
and records time varying accelerations of the trunk that
ranges in magnitude from ± 6g. The ActiGraph acceler-
ometer is a valid and reliable measure of ambulatory
physical activity in children and adolescents with CP [57,
131]. ActiGraph-based estimates of Metabolic Equiva-
lents (METS) is a valid method to differentiate between
varying intensities of walking (slow, comfortable and
brisk paced) in children and adolescents with CP using
previously published cut points for TDC [131]. The
ActiGraph has good to excellent reliability with stepping
tasks (ICC = 0.66), light and moderate walking (ICC =
0.8) and vigorous walking (ICC = 0.7) in independently
ambulant children and adolescents (aged 8 to 16 years)
with CP [57]. In community dwelling adults with an
ABI, ActiGraph-based estimates when compared to
portable indirect calorimetry (Cosmed K4b2) as a criter-
ion measure, provided a valid index of activity across dif-
ferent levels of walking intensities [132]. It is estimated
that between four and five days of monitoring are re-
quired to reliably estimate daily physical activity in TDC
[133]. Both weekdays and weekends will be included in
the monitoring period due to marked differences in
physical activity behaviour.
ActiGraphs will be fitted during assessment (on the
dominant hip) and worn during waking hours for four
days following assessment and training days. After four
days it will be returned by courier for data extraction
and analysis using the manufacturers ActiLife software.
An activity log completed by the parents/guardians
coupled with an ActiGraph to validate the ActiGraph
accelerations against reported wear time will be given.
Raw acceleration data will be considered for analysis
where accelerations are recorded for >4h per day on at
least one weekend and one weekday.
Canadian Occupational Performance Measure (COPM)
The COPM will be used to measure self-perception of
performance and satisfaction with performance of indivi-
dualised occupational goals [54, 134]. One occupational
therapist will administer the COPM with the child/
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adolescent and parent at the baseline assessment. Care-
givers and children will identify areas of difficulty in
everyday occupational performance and prioritise these
on a scale of 1 to 10. Three to five priority goals will be
identified and perceived level of performance and
satisfaction with performance will be rated on a scale
between 1 and 10 (1 indicates poor performance/low
satisfaction and 10 indicates very good performance/
high satisfaction). An average score for performance
and satisfaction is calculated [93]. Ratings from care-
givers will be used for children under the age of eight
years of age, and ratings from children over eight years
of age in collaboration with their caregiver will be re-
ported. The COPM was designed for all ages and dis-
ability groups, has good evidence of construct, content
and criterion validity and good test re-test reliability for
performance and satisfaction scores (ICC 0.76–0.89)
[134–136]. The COPM is responsive to change in
paediatric clinical trials [137, 138]. A change of two
points or greater has been reported as being clinically
significant [54].
Physical capacity and performance test-retest reproducibility
and validity
Participants will have the option to participate in test-
retest reproducibility study of repmax of functional
strength exercises, 6MWT, HiMAT and TUG test over
two days at the testing facility during baseline (for the
immediate group) or 20 week follow-up assessments (for
the waitlist group). Accuracy between hand-timed and
videos scores during the HiMAT and TUG test will also
be investigated. Testing will be performed in the same
order by the same physiotherapist.
Participants will also have the option to participate in the
validation for the ActiGraph accelerometer as a measure of
physical activity intensity in children and adolescents with
an ABI. To validate the ActiGraph accelerometer, partici-
pants will be asked to return for one assessment day after
they have completed the primary end-point (20 week as-
sessment) for the RCT. For the validity protocol, partici-
pants will be asked to rest for a 5–10 min period and then
conduct selected light, moderate and vigorous assessment
tasks, interspersed with 5–10 min rest periods in a standar-
dised manner. To finish, they will complete a 15 min Mitii™
training program adjusted for their individual capacity.
These tasks will be performed whilst wearing an ActiGraph
accelerometer, heart rate monitor and a portable indirect
calorimeter (MetaMax®). For test-retest reproducibility of
the ActiGraph accelerometer, participants will rest for
five minutes before conducting selected light, moderate
and vigorous assessment tasks, interspersed with 5 min
rest period in a standardised manner over the baseline
assessment and training days.
MobQues47
Activity limitations will be measured using the Mob-
Ques.[59] The MobQues was originally designed to
measure the mobility limitations a child with CP expe-
riences in everyday life and to cover a broad range of
severity of mobility limitations, as rated by their par-
ents. Two versions of the MobQues are available;
the MobQues47 and the MobQues28 with 47 and 28
mobility items, respectively. Response options for the
MobQues are: Impossible without help (score 0), very
difficult (score 1), somewhat difficult (score 2), slightly
difficult (score 3) or not difficult at all (score 4). Total
scores are calculated by adding up the item scores.
Total item scores are then divided by the maximum
possible score (i.e. 188 for MobQues47 and 112 for the
MobQues28) and multiplied by 100 to obtain values on
a scale of 0 to 100 (with lower scores representing more
severe mobility limitations). For research purposes, the
shorter version (MobQues28) is recommended as it has
stronger psychometric properties (based on Rasch ana-
lysis) whereas; the MobQues47 can be used for clinical
applications, to assess the child’s limitations in a wide
variety of mobility activities [59]. Content validity has
been demonstrated as 46 out of the 47 test questions
related to ‘mobility’ according the definitions in the
ICF. Construct validity was demonstrated as MobQues
scores decreased with increasing GMFCS levels (p <
0.001). In a subgroup of 162 children, MobQues score
was positively correlated to GMFM-66 (Mobques47,
r = 0.75; MobQues28, r = 0.67, p < 0.001) [139]. Reliabil-
ity has also been demonstrated. For inter-rater reliabil-
ity, high ICC were found for the MobQues47 (ICC =
0.92) and MobQues28 (ICC = 0.87). The SEM was 7.8
and 8.9 respectively. Intra-rater was higher with ICC of
0.96–0.99 and lower SEM (3.5–4.9) for both versions of
the test [59]. The English version has not yet been
cross-validated therefore, the results demonstrated may
differ slightly to that in an English speaking population.
The MobQues47 will be collected at baseline (to allow
cross-validation) and in follow-up assessments, the
MobQues28 will be used (stronger psychometric prop-
erties). This questionnaire will be available for care-
givers to fill out in either paper or online format.
Participation domain
The Child and Adolescent Scale of Environment (CASE)
The CASE was initially developed as part of the Child
and Family Follow-Up Survey (CFFS) to monitor out-
comes and needs of children with an ABI (as informed
by the ICF) [140]. The CASE consists of 18 items on a
three point ordinal scale (no, little or big problem) that
asks parents about the impact of problems experienced
with physical, social and attitudinal environment features
of the child’s home, social and community and those
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related to the quality and availability of services of assist-
ance that the child receives or might need. The CASE can
be administered in five minutes and no specialist training
is needed to administer it. The CASE has reported evi-
dence for test re-test reliability (ICC = 0.75), internal
consistency (α = 0.84–0.91) and construct/discrimin-
ant validity. Higher CASE scores (greater extent of en-
vironmental problem) were significantly associated
with lower scores on the Child Adolescent Scale of
Participation (CASP, more restricted participation,
r = −0.57, [141]; r = −0.43, [142]) and on the Paediatric
Evaluation of Disability Index (PEDI, more limited
functional skills) mobility (r = −0.28) and social func-
tion (r = −0.31) subscales [143]. This questionnaire will
be available for parents and/or guardians to fill out in
either paper or online format.
The Child and Adolescent Scale of Participation (CASP)
The CASP measures participation of children with an ABI
in home, school and community activities compared to typ-
ically developing children of the same age as reported by
parents or guardians [140, 142]. Like the CASE, the CASP
was developed as part of the CFFS to monitor outcomes
and needs of children with an ABI. The CASP consists of
20 ordinal scaled items in four subsections: 1) Home par-
ticipation, 2) Community participation, 3) School participa-
tion, and 4) Home and community living activities. The 20
items are rated on a four-point scale: “Age Expected (Full
participation),” “Somewhat Restricted,” “Very Restricted,”
“Unable”. A “Not Applicable” response can be selected
when the item reflects an activity that the child would not
be expected to participate in due to age (e.g. work). The
CASP also includes open-ended questions that ask
about effective strategies and supports and barriers
that affect participation. The CASP takes about 10
min to administer and no specific training is needed.
The CASP has reported evidence of test re-test reli-
ability (ICC = 0.94), internal consistency (α ≥ 0.96) and
construct and discriminant validity. Moderate correla-
tions were found between the CASP scores and scores
from measures of functional activity performance on
the PEDI (r = 0.51–0.75), extent of child impairment
on the Child and Adolescent Factors Inventory [CAFI
(r = −0.58 to −0.66) and problems in the physical and
social environment as measured by the CASE (r = −
0.43 to −0.57) [140, 142, 143]. Significant differences
in CASP scores were found related to type of disability
[142]. Children without disabilities, on average, had
significantly higher CASP scores than children with
disabilities. No significant differences were found re-
lated to age category [142]. The CASP will be available
for parents and/or guardians to fill out in paper or
online format.
Participation and Environment Measure for Children and
Youth (PEM-CY)
This parent-report instrument examines the frequency
and level of participation in home, school and com-
munity settings [144]. In addition, the measure also
addresses whether the surrounding environment
makes it easier or harder to participate. There are 10
items in the home section, five in the school section
and 10 in the community setting. For each item, the
parent is asked to identify how frequently (over the
past four months) the child has participated (eight op-
tions: daily to never); how involved the child typically
is while participating (five point scale: very involved to
minimally involved); and whether the parent would
like to see the child’s participation in this type of activ-
ity change (no or yes, with five options for the type of
change desired). After each section the parent is then
asked to report on whether certain feature of the
environmental makes it easier or harder for the child
to participate. The PEM-CY has reported moderate to
good internal consistency (0.59 and above) and test-
retest reliability (0.58 and above) in a population of
children (aged 5 to 17 years) with and without disabil-
ities residing in the United States of America and
Canada (n = 576) [144]. The PEM-CY will be collected
at baseline using either paper or online questionnaire
format to gain an understanding of the participation
of children and adolescents and the impact of environ-
mental support.
Strengths and Difficulties Questionnaire (SDQ)
The Strengths and Difficulties Questionnaire (SDQ)
[145, 146] is a 33 item parent-rated questionnaire that
is used to assess parents’ perceptions of pro-social and
difficult behaviours in their child. Parents are required
to respond to 25 questions about their child’s behaviour
in the last six-months using a three-point likert scale
(i.e., “0” = not true to “2” = certainly true). These 25
questions combine to create five sub-scales of: fre-
quency of emotional symptoms; conduct problems; in-
attention/hyperactivity; peer problems; and prosocial
behaviour (e.g. “considerate of other people’s feelings”).
A total score for each scale (0–10) and overall total
difficulties score (0–40) will be calculated, with higher
scores indicating more distress on all scales except
prosocial behaviour. Scores of 17 or above for the total
difficulties scale will be used a clinical cut-off point.
Scores from the five sub-scales and the overall difficul-
ties scale will be used as a measure of the child’s psy-
chological functioning. The overall total difficulties
score has been demonstrated to have moderate to high
internal consistency (α = 0.73–0.82) and test-retest re-
liability (r = 0.77–0.85) [147].
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Quality of Life
Kidscreen-52
The Kidscreen-52 is a generic measure of QOL which will
be used to compare parents report of QOL for children
with ABI compared to their age, gender and matched pair.
The Kidscreen-52 has been described as the most useful
generic measure of QOL of children as it addresses the
multidimensional construct of QOL through various do-
mains and focuses specifically on the well-being of children.
It was developed to implement the views of children,
through focus group work of 22,110 children [148]. The
Kidscreen-52 Questionnaire takes 15–20 min to complete
and consists of 52 questions across 10 domains: Physical
Well-being; Psychological Well-being; Moods and Emo-
tions; Self-Perception; Autonomy; Parent Relations and
Home Life; Social Support and Peers; School Environment;
Social Acceptance (Bullying); and Financial Resources. The
items use a five point Likert-type scale to assess either the
frequency of certain behaviours/feelings or, in a small num-
ber of cases, the intensity of attitude. Higher scores on the
Kidscreen-52 indicate better health-related QOL and well-
being. During development of this measure, a child self-
report was administered for children 8–18 years old and a
parent proxy version was administered for parents of
children 5–18 years. Children below the age of eight were
unable to self-report as their reports were likely to be unre-
liable. Reliability was calculated by Cronbach’s Alphas and
ranged between 0.76 and 0.89 throughout the 10 domains
of health-related QOL. Convergent and discriminant valid-
ity were tested using information of child’s physical and
mental health. Correlations of up to 0.55 were found when
correlating the Kidscreen-52 dimensions with frequency of
physical complaints [148].
CHU-9D
The Child Health Utility (CHU-9D) will be used to meas-
ure participant QOL (parent/proxy completion). This rela-
tively new instrument is specifically designed to measure
health-related QOL in children and those affected by a
disability from a young age [149]. It contains nine do-
mains: worried, sad, pain, tired, annoyed, school/home-
work, sleep, daily routine and able to join activities. Each
domain has five response levels. The CHU-9D is scored
on a scale of 0–100 using preference weights which allow
the calculation of Quality Adjusted Life years (QALYs) for
use in economic evaluation. Preference weights are avail-
able from a general adult United Kingdom population and
from an Australian population of 11–17 year old adoles-
cents [150, 151].
Environmental and personal factors
The same study questionnaire which was used for a
previous Mitii™ protocol will be used [89]. This ques-
tionnaire was developed to capture important demographic
information that has been shown in the literature to influ-
ence participation. Information includes family ethnicity,
household income, socio-economic status, family structure
and supports, and family interests. The questionnaire will
be administered at baseline. A measure of social advantage/
disadvantage will also be derived from postcode of resi-
dence using the Index of Relative Socio-economic Advan-
tage/Disadvantage (2006) from the Australian Bureau of
Statistics [152]. Deciles will be reported on a continuum
with lower scores reflecting greater socio-economic dis-
advantage and higher scores reflecting socio-economic
advantage.
Exit interview
An exit interview will be conducted with participants
and their parents or guardians to investigate engagement in
web-based therapy in the home environment to guide fu-
ture clinical implementation. Semi-structured interviews
will be conducted by a therapist who is not involved in the
conduct of the study, audio recorded and transcribed
verbatim until saturation of data is achieved. Transcripts
will be analysed using an inductive approach.
Healthcare costs
Virtual trainers will keep a diary to document the
amount of time taken to monitor and progress pro-
grams, contact families and troubleshoot any technical
difficulties. These data will be used to estimate the costs
associated of the Mitii™ program. A cost will be assigned
to each resource; allied health visits by state health wage
rates; medical care and diagnostic/investigational ser-
vices according to the fees in the national Medicare Ben-
efits Schedule [153].
Statistical analysis
Sample size
The primary basis for sample size calculation for this
study is adequate power (80 %) to detect a clinically im-
portant difference for the comparison between the func-
tional effects of Mitii™ (as measured on the AMPS and
repmax of functional strength exercises) and usual care at
the primary endpoint (20 weeks). This study examines a
continuous response variable from matched pairs, waitlist
control and immediate-intervention participants with one
waitlist control per immediate intervention participant.
In a previous study of Mitii™ in children with unilat-
eral CP (n = 102) the response within each group was
normally distributed with SD 0.40 on the AMPS process
subscales [49]. To detect a real changes in ADL process-
ing abilities (0.30 units of greater) [92] between groups
with 80 % power and α = 0.05, 29 children from each
group are required to complete 20 week follow-up
assessments.
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For repmax of functional strength exercises in a previ-
ous reliability study, the response within each subject
group was normally distributed with a SD of five sit-to-
stand repetitions [93]. If the clinically important differ-
ence between groups is four repetitions we will need 26
children from each group to complete 20 week follow-
up assessments with, α = 0.05 [47].
Based on a previous RCT using 3T fMRI there were
activation in the representative cortex for motor studies
with good signal to noise ratio. Participant numbers
will allow for some loss of information due to partici-
pant refusal (10 %) and scans where motion is a con-
founder (10 %). To detect fMRI changes between
baseline to follow-up assessment (20 weeks) with 80 %
power and a SD of 0.65, we will require 39 partici-
pants. If the supplementary motor area (SMA) is consid-
ered, given coefficients of variation (COV) for control
subjects performing motor tasks (COV of 11 % in PM1
and 35 % in SMA, and activation signal of 1.5 %, we will
be able to detect differences in percentage activation levels
over time as small as 0.47.
Statistical analysis
Analysis will follow standard principles for RCTs. Pri-
mary and secondary outcomes will be assessed using
two-group comparisons on all participants with evalu-
able data at 20 week follow-up assessments on an
intention-to-treat basis. Statistical significance will be set
at p < 0.05 for primary outcomes. Statistical significance
for secondary outcomes will be defined separately for
each suite of analyses prior to analyses being under-
taken. Each significance level will be set to account for
both type I and type II error rates due to the number of
multiple comparisons. Validity of results will be checked
using baseline and general descriptive information avail-
able for all eligible families. This includes comparing the
key characteristics of families who completed the study
with those who enrolled in the study but did not
complete, and those who did not enrol. The primary
outcome measures immediately post-intervention at 20
weeks will be AMPS and repmax of functional strength
exercises. Outcomes between treatment groups will be
compared at follow-up using linear regression models,
where treatment group (intervention or waitlist) and
baseline score will be entered in as main effects. Second-
ary analyses will compare the outcomes between groups
for physical activity, participation (CASE and CASP) and
QOL (domains of Kidscreen-52).
For reproducibility studies (AMPS, physical activity
capacity and performance measures and attention and
executive functioning measures), units of variance will
be assessed using an analysis of variance (ANOVA)
model with Bland Altman Plots with 95 % limits of
agreement (LOA). Intra-class correlation coefficients
(model: 2-way mixed effects with absolute agreement)
and 95 % confidence intervals will be calculated and
interpreted as greater than 0.75 as excellent correlation,
between 0.4 and 0.75 as adequate and less than 0.40,
poor correlation [154]. The SEM will be calculated
using [155]:
SEM ¼ Standard Deviation SDð Þ 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1−ICCð Þ
p
The MDC will be calculated using [155]:
MDC ¼ SEM  1:96 
ffiffiffi
2
p
For attention and executive functioning measures, reli-
able change indexes (RCI) will be calculated using [156]:
RCI ¼ retestscore −initialscoreð Þ
 standard error of difference; SDiffð Þ
Validity of the ActiGraph accelerometer using oxygen
uptake (VO2) as the criterion measure will be assessed
using one-way repeated-measures ANOVA with post-
hoc pair-wise comparisons with Bonferroni corrections
for multiple comparisons.
Economic analysis
A within trial cost-utility analysis will be conducted to
compare the Mitii™ intervention to usual care from both
a health care and societal perspective. The costs and out-
comes for each group will be compared using incremental
cost-effectiveness ratios (ICERs) (i.e. [cost Mitii™ – cost
waitlist/ [QALYs Mitii™ – QALYs waitlist].
The CHU-9D will be scored using the Australian pref-
erence weights and total QALYs estimated for the period
of the trial [151]. Key variables (e.g. cost of delivering
the intervention, scoring the CHU-9D with the UK pref-
erence weights) will be altered and tested in one-way
and multi-way sensitivity analyses to generate a range of
possible ICERs for the intervention. Economic data will
be bootstrapped to generate 95 % CI.
MRI analysis
Structural parcellation
Cortical reconstruction and volumetric segmentation
will be performed using the MPRAGE images with the
Freesurfer image analysis suite (http://surfer.nmr.mgh.-
harvard.edu). Briefly, non-brain tissue will be removed
using a hybrid watershed/surface deformation procedure
[157]. Subcortical white matter and deep grey matter
volumetric structures will be segmented automatically
and intensity inhomogeneity of the images will be cor-
rected [158, 159]. The cerebral cortex will be parcellated
into 34 units per hemisphere based on gyral and sulcal
structure [160, 161]. In addition to cortical regions, the
left and right thalamus, left and right cerebellum and
brain stem will be extracted. The accuracy of the cortical
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and subcortical parcellation will be assessed visually. An
axial slice will be manually defined below the inferior
most slice on which the pons was visible to include only
the most caudal part of the brain stem.
A termination mask will be generated to prevent diffu-
sion tractography streamlines from crossing the cortical
folds as described previously [162]. Briefly, the interface
between white matter and grey matter will be identified
and this boundary shifted one voxel into the grey matter.
Streamlines will be terminated when penetrating more
than one voxel deep into grey matter.
Diffusion processing
An extensive pre-processing procedure will be followed
to detect and correct for image artefacts caused by
involuntary head motion, cardiac pulsation and image
distortions [163]. In brief, images with within-volume
movement will be detected using the discontinuity index
and excluded from further analysis [164]. Image distor-
tions caused by susceptibility in homogeneities will be
reduced using the field map, employing FUGUE and
PRELUDE tools available with FSL and intensity in
homogeneities will be removed using n3 correction [165,
159]. Subsequently, signal intensity outlier voxels (caused
by cardiac pulsation, head motion and other artefacts)
will be detected and replaced using DROP-R [166].
DROP-R will be modified from the originally proposed
method to employ a higher order model of the diffusion
signal suitable for the detection and replacement of out-
liers in high b-value diffusion data (HOMOR) [167].
Between-volume registration to account for head move-
ment during the scan time will be performed using
FMAM with adjustment of the b-matrix [168–170] .
Following these steps, fractional anisotrophy (FA) will
be estimated from the corrected diffusion data. Con-
strained spherical deconvolution (http://nitrc.org/pro-
jects/mrtrix) will be employed to estimate the fibre
orientation distribution for tractography at maximum
harmonic order [85, 171].
Connectome construction
Diffusion and structural data will be co-registered using
a rigid-body transformation with FLIRT (part of FSL) by
registering the FA to the skull-stripped MPRAGE [165].
Registration accuracy will be checked visually. Five mil-
lion probabilistic streamlines will be generated, seeding
throughout the entire brain volume, to produce a whole
brain tractogram. Streamlines will be prevented from
crossing cortical folds by applying the termination mask
generated from structural data (see section Structural
parcellation). Cortico-cortical, cortico-thalamic, cortico-
cerebellar and cerebello-cerebellar connections will be
extracted from the whole brain tractogram by hit-testing
both terminal end points of every streamline with every
cortical and cerebellar region. For brain stem connec-
tions, only one terminal endpoint will be required to res-
ide within the cortical, thalamic or cerebellar region,
with any part of the streamline passing through the
brain stem. For every possible link between any pair of
nodes, the number of connecting streamlines will be noted.
Median FA values will be calculated by sampling the diffu-
sion maps at every step of the selected streamlines. Con-
nections with fewer than 250 streamlines (average) in
children with typical development will be excluded from
further analysis (threshold determined empirically). Results
will be recorded in enriched connectivity matrices.
Statistical analysis of the brain network
Statistical analysis of the brain network will be performed
using the network based statistic toolbox for Matlab
(https://sites.google.com/site/bctnet/comparison/nbs) [172].
A general linear model will be used to identify differences
in FA between participant groups for every connection,
using age as a confounding variable.
Discussion
This proposed study presents the background and design
for a matched pairs, randomised waitlist controlled trial
comparing 20 weeks of intensive Mitii™ training to usual
care for children with an ABI. This study is the first to
investigate the effects of a multi-modal training program
delivered over the internet compared to usual care and
will also be the largest of its type in this population. Fur-
thermore, we will be evaluating outcomes of the Mitii™
training program across all domains of the ICF using the
most valid and reliable assessment tools available for
use. We anticipate that the results of this study will be
disseminated through peer reviewed journals and na-
tional and international academic conferences.
Additional files
Additional file 1: MitiiTM ABI participant manual.
Additional file 2: MitiiTM ABI rewards chart (child version).
Additional file 3: MitiiTM ABI modules.
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